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Abstract
This thesis studies two particular bacterial outer membrane proteins called OmpC and
Wzi, focusing on their expression, purification, crystallization and X-ray structure
determination.
A series of four naturally occurring OmpC mutants were isolated from a single patient
with an E. coli infection of liver cysts. The isolated E. coli strains progressively exhibited
increasing breadth of antibiotic resistance in which OmpC was predicted to take a partial
role. We carried out an assay in which a strain of E. coli lacking OmpC was used to
express the first (antibiotic sensitive) and the last (antibiotic resistant) of the clinical
OmpC mutants and drug permeation assessed. Single channel conductance measurements
were carried out and the X-ray structures for all the isolates were determined. Protein
stability was assessed. With these data we propose that changes in the transverse electric
field, not the pore size, underlie the clinically observed resistance to the antibiotics. This
is the first demonstration of this strategy for antibiotic resistance.
Wzi is a novel outer membrane protein involved in the biosynthesis and translocation
mechanism of the K30 antigen from E. coli. The mechanism is a complicated process that
requires several proteins including outer and inner membrane proteins. The protein Wzi
was expressed, purified and crystallized. Initial crystals were tested and diffracted to 15
Å. After optimization, a crystal diffracting to 2.4Å has been obtained.
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1Chapter 1
Introduction
2Overview
Structure determination for membrane proteins is considered the biggest challenge among
crystallography community today. Indeed, among more than 60000 PDB entries only 554
are membrane protein structures (October 2009); in other words, less than 1% of known
structures are membrane proteins. However, it is predicted that 20-30% of the genomes of
eubacterial, archaean and eukaryotic organisms encodes for membrane proteins and 70%
of today’s drugs act via membrane proteins. Therefore, it is crucial to determine the
membrane proteins structures which will provide insights and basis for rational drug
design.
One may ask why it is so difficult to obtain membrane protein crystal structures. In this
chapter, the environment of membrane proteins is discussed and their difficult nature for
crystallization explained. All the currently known structures of bacterial outer membrane
structures are summarized.
31.1 The Gram-negative bacteria cell envelope
The cell envelope comprises three layers in Gram-negative bacteria such as Escherichia
coli. These layers include the outer membrane (OM), inner membrane (IM) and a
periplasmic layer in between (Nikaido and Nakae, 1979). Both membranes are bilayers
composed by two leaflets, while the periplasmic layer is a gel-like fluidic band comprises
proteins and peptidoglycan (Nikaido and Nakae, 1979). The inner (cytoplasmic) membrane
is a symmetrical bilayer which is exclusively composed of phospholipids. Because of the
hydrophobic nature of phospholipids, the IM represents a real diffusion barrier for
hydrophilic solutes. Polar molecules such as sugars, nucleotides and ions move across the
IM via specific integral membrane protein transporters (Nikaido, 2003). In contrast to the
IM, the OM is a highly asymmetric bilayer which is composed by phospholipids in the
inner leaflet and lipopolysaccharide (LPS) in the outer leaflet. The LPS comprises three
domains: lipid A, core oligosaccharide, and O polysaccharides (O antigen repeats) (Figure
1.1.1) (Raetz and Whitfield, 2002). Many saccharides in the LPS are acidic and negatively
charged. The charged nature of the outside LPS layer confers bacteria with high resistance
to hydrophobic compounds; the lipid portion is almost impermeable to all charged
molecules. Cells must import and export molecules to and from the environment; therefore,
the OM contains channel-forming proteins, mainly a class of channels called porins that
allow this (Nikaido, 2003).
4Figure 1.1.1 Schematic view of the inner and outer membranes of E. coli K-12. In the
figure MDO is membrane-derived oligosaccharides; Kdo stands for
3-deoxy-D-manno-oct-2-ulosonic acid; PPEtn is short for pyrophosphorylethanolamine
(Picture from Raetz and Whitfield, 2002).
51.2 The importance of membrane proteins and challenges of
crystallization
Although the lipid bilayer comprises the backbone of Gram-negative cell membranes,
membrane proteins perform the most of the specific functions, including respiration, signal
transduction and molecular transport (Byrne and Iwata, 2002). Genome analysis of
eubacterial, archaean, and eukaryotic organisms predicted that 20–30% of the open reading
frames encode integral membrane proteins (Wallin and von Heijne, 1998). Moreover,
many membrane proteins are critical components of genetic disorders and it is estimated
that membrane proteins are targeted by more than 70% of today’s drugs (Byrne and Iwata,
2002). It is therefore important to obtain high resolution membrane protein structures to
understand their functions, which will provide insights and basis for new drugs and new
therapies. The sequence and function of many membrane proteins are known, but only a
small number of structures are elucidated to date. According to the “Membrane Proteins of
Known 3D Structure” website of S. H. White (http://blanco.biomol.uci.edu/Membr-
ane_Proteins_xtal.html), there are currently (October 2009) 554 membrane protein
structures of which 204 are unique, in comparison to the more than 60000 structures of
water-soluble proteins deposited in PDB (Protein Data Bank, October 2009,
http://www.rcsb.org/pdb).
6As nowadays, structure biology is becoming routine: expression, purification,
crystallization and X-ray data analysis. Why it is still so hard to solve membrane protein
structures? The barriers impact upon every step of structural determination. The
recombinant expression and the following purification of sufficient amounts of membrane
protein are often difficult. Moreover, numerous crystallization trials are necessary to get
crystals that diffract to high resolution. Because of these reasons, membrane proteins of
known structure in the database in early days are mainly naturally abundant. However,
most membrane proteins are present in the cell at low concentrations (Hunte and Michel,
2002).
All membrane proteins that are transported to the outer membrane contain an N-terminal
signal peptide, usually ~20 amino acids long, which directs them through the translocon in
the IM to the periplasm. The signal peptide is removed during translocation by signal
peptidases prior to protein folding and insertion into the membrane. For the recombinant
production of outer membrane proteins it is important to take into account the signal
peptide. E. coli is usually used as the host organism for the overexpression of either native
or heterologous recombinant outer membrane proteins. In some cases the E. coli signal
peptidase cannot process the signal peptide of heterologous proteins, resulting in the
formation of inclusion bodies or no expression (Baneyx, 1999). Manipulation of the signal
peptide of the target protein can resolve this problem (Hearn et al., 2008). Absence of the
signal peptide from the recombinant protein results in the production of the target protein
in the form of inclusion bodies. Outer membrane proteins expressed as inclusion bodies in
7the absence of a signal peptide can be extracted and purified in the presence of urea in a
relatively straightforward manner. A successful example of this method for protein
production is the crystal structure of OmpG from E. coli (Yildiz et al., 2006).
Extraction and solubilisation of membrane proteins is challenging because of the extensive
hydrophobic/amphiphilic surfaces. When the native membrane is removed during
extraction and purification of the protein, suitable detergents have to replace the lipid that
was in the native environment. Once extracted and purified, the membrane protein is in a
form of protein-detergent complexes, or PDCs, which is the real starting material for
membrane protein crystallization.
Membrane proteins do not crystallize readily. PDCs form crystals at the polar surfaces of
the protein protruding from the detergent micelle, and most PDCs have only limited
accessible hydrophilic surfaces (Hunte and Michel, 2002). The use of additives, such as
heptane-triol, has played a significant role in membrane protein crystallization (Wiener,
2004). A goal has been to enlarge the polar surface of the protein, most often by attaching
polar domains with specifically binding antibody fragments, to enhance crystallization
(Ostermeier et al., 1995). The use of recombinant antibody fragments, in a form of either
Fv (variable fragment, ~28 kDa) or Fab (fragment antibody binding, ~56 kDa), has been
shown to improve the crystallization of several membrane proteins (Hunte et al., 2000;
Iwata et al., 1995; Jiang et al., 2003).
81.3 Structures of bacterial outer membrane proteins
1.3.1 General and substrate-specific porins
Porins were the first outer membrane proteins (Omps) to be studied. The first x-ray
structure of a porin from Rhodobacter capsulatus was determined in 1990 (Weiss et al.,
1990) quickly followed by OmpF and PhoE from Escherichia coli (Cowan et al., 1992), a
porin from Rhodopseudomonas blastica (Kreusch and Schulz, 1994), OmpK36 from
Klebsiella pnueumoniae (Dutzler et al., 1999), Omp32 from Comamonas acidovorans
(Zeth et al., 2000) and Delftia acidovorans (Zachariae et al., 2006), and more recently
OmpC from E. coli K12 (Basle et al., 2006). These porins have the same basic architecture
consisting of 16-stranded hollow β-barrels. They have all crystallized as trimers, with a 
three fold axis normal the membrane plane. The crystal structure of OmpC (Basle et al.,
2006) is shown in Figure 1.3.1.1. The hydrophobic interactions between monomeric barrel
surfaces stabilize the trimer. The barrels all show eight tight turns on the periplasmic side
and eight large, irregular loops (L1 to L8) on the extracellular side. L2 interacts with the
neighboring monomer to stabilize the trimer (Phale et al., 1998). L3 folds into the barrel
forming a “constriction zone” at about midway into the barrel. As a result when viewed via
a space-filling model, the central pore has an hourglass shape. In the constriction zone,
there are acidic residues in L3 with a cluster of basic residues at the opposite barrel. These
opposite charged residues created a transverse electrostatic field which is thought to make
an important contribution to porin properties (Nikaido, 2003).
9Figure 1.3.1.1 Structure of OmpC porin from E. coli (PDB code: 2J1N). (A) View of the
trimer from the outside of membrane, loop L2 is colored in orange, L3 is in purple. (B)
Side view of the monomer. (C) View of the constriction zone of the channel, featuring the
opposite-charged residues that form the electrostatic field.
These porins are known as “general porins” and are water-filled channels with no
particular substrate specificity. Their biological role is to control the passage of hydrophilic
solutes based on the substrate molecular size (Nikaido, 2003). In addition to general porins,
bacteria have substrate-specific porins which are also trimeric β-barrel proteins. The 
substrate-specific porins include the maltose-specific channel LamB from E. coli
(Schirmer et al., 1995) and its homolog from Salmonella typhimurium (Phale et al., 1997),
the sucrose-specific channel ScrY from S. typhimurium (Forst et al., 1998), and from
Pseudomonas aeruginosa the phosphate-specific transporters OprP (Moraes et al., 2007),
OprD (Biswas et al., 2007) and OpdK (Biswas et al., 2008).
A B C
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Monomers of LamB and ScrY have 18 β-stranded structures instead of the 16 observed in 
general porins and also form a homotrimer, with the three-fold parallel to the membrane
normal. Once again L3 folds back into the β-barrel (Figure 1.3.1.2). X-ray structure 
analysis of sugar-soaked LamB crystal identified a substrate translocation pathway
(Schirmer et al., 1995) with of a number of aromatic amino acids as the “greasy slide”
(Figure 1.3.1.2B) lined by polar residues the “ionic track” (Schirmer et al., 1995). The
hydrophobic face of sugar makes van der Waals’ contacts with the greasy slide while the
sugar hydroxyl groups make hydrogen bonds with the ionic track. It has been proposed that
substrates move through the channel via a sequence of hydrogen bond making and
breaking steps (Schirmer et al., 1995). The channel-lining residues are mostly conserved
between LamB and ScrY, but the differences confer the specificity.
Figure 1.3.1.2 Structure of LamB (PDB code: 1MAL). (A) View of the trimer from
extracellular side. (B) Aromatic residues that contribute to the greasy slide are shown in
purple.
A B
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The P. aeruginosa OprP is a 16-stranded antiparallel β-barrel but unusually OprP has an 
extended periplasmic N terminus (Figure 1.3.1.3A) involved in stabilizing the trimer
(Moraes et al., 2007). Inside the channel, there is a nine-residue arginine “ladder” spanning
from the extracellular surface down to the constriction zone (Figure 1.3.1.3B). This ladder
is proposed to control the transit of the phosphate anion (Moraes et al., 2007). The inner
periplasmic surface is coated by lysine residues, creating an ‘electropositive sink’ that
attracts the phosphates through the channel.
Figure 1.3.1.3 Structure of OprP (PDB code: 2O4V). (A) Side view of OprP trimer, the
tricorn N terminal strands are colored red. (B) The arginine ladder located on the upper
portion of the monomer of OprP is shown in stick representation
OprD and OpdK are 18 β-strand substrate-specific porins from P. aeruginosa; OprD takes
up basic amino acids such as lysine and arginine (Trias and Nikaido, 1990) and OpdK is
responsible for taking up vanillate and related small aromatic acids (Biswas et al., 2008).
A B
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They both crystallized as monomers as shown by their crystal packing. However,
biochemical and biophysical studies showed that they form trimers in the bacterial outer
membrane. Similar to OprP, OprD contains a ladder of arginine and lysine residues. In
OpdK, only some of the ladder residues are present. Both OprD and OprK have similar
charge distribution of the residues lining the pore. However, in OprD, the periplasmic
funnel surface is negatively charged whilst in OpdK it is positively charged. This
difference seems to underlie the differing substrate specificities.
1.3.2 Dimeric β-barrel proteins 
Besides trimeric 16 to 18 β-strand porins, bacteria also have dimeric β-barrel proteins. The 
first dimeric structure was the outer membrane phospholipase A (OMPLA). OMPLA is an
integral membrane enzyme which catalyzes the hydrolysis of acyl ester bonds in
phospholipids in a Ca2+-dependent manner (Ubarretxena-Belandia et al., 1998).
Dimerization is essential for its function (Ubarretxena-Belandia et al., 1998).The monomer
of OMPLA is a 12-stranded antiparallel β-barrel and like the porins, has long extracellular 
loops and short periplasmic turns. The interior OMPLA is polar with a hydrogen-bonding
network, however the central pore of OMPLA does not apparently function as a channel
(Snijder et al., 1999). The dimer interface is formed by one side of the barrel (Figure
1.3.2.1) and two Ca2+ ions are adjacent to the interface. The active sites lie at the outer
edge of the barrel and at the interface between the two monomers.
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PapC is the translocation pore responsible for the assembly of adhesive pili on the surface
of gram-negative pathogenic bacteria acting as P pilus usher (Remaut et al., 2008). P pili
are complex extended fibers that are produced by pyelonephritic strains of E. coli. PapC is
considered to the prototype for bacterial usher proteins and is found as a dimer arranged
similarly to that seen for OMPLA. Each PapC monomer is a 24 β-stranded monomer (the 
largest barrel observed to date). A long sequence connects the two β-strands β6 and β7 and 
is located in the centre of the pore forming a “plug” domain. The plug domain is a
six-stranded β-sandwich, the plane of the strands is parallel to the assumed membrane 
plane. The plug completely occludes the translocation pore and is held in place by a
β-hairpin (connecting strands β5 and β6) that folds into the channel lumen. The only helix 
in the structure sits above (on the extracellular side) the β-hairpin (Figure 1.3.2.2). The 
inward curvature of the β5-6 hairpin creates a gap in the side of the β-barrel that is 
expected to extend into the outer membrane bilayer (Figure 1.3.2.2). This partly “missing
stave” is thus far a unique feature.
Figure 1.3.2.1 Structure of dimeric OMPLA
(PDB code: 1QD6) viewed from the
extracellular side. The two black spheres
represent two calcium ions, the substrate
analogue, hexadecanesulphonyl-fluoride, at
the active sites are colored purple.
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Figure 1.3.2.2 Structure of PapC translocation domain (PDB code: 2VQI). (A) The PapC
translocation channel viewed from the extracellular side. The plug domain, the β5-6 
hairpin, and the α-helix are colored purple, orange and blue, respectively. (B) β-barrel 
viewed from side. Structural elements are colored as in (A), the abnormal β5-6 is labeled.  
β5-6A B
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1.3.3 TonB-dependent active transporters
In addition to trimers and dimers, monomeric β-barrel protein structures have been 
determined and they include structural proteins, enzymes and transporters. The
TonB-dependent active transporters are 22 β-stranded barrel and use the proton motive 
force to transport specific substrates. The proton motive force acts from the cytoplasmic
membrane through the TonB-ExbB-ExbD energy transducing complex across the bacterial
outer membrane (Moeck and Coulton, 1998). Despite low sequence similarities (~15%) the
iron-siderophore transporters FhuA, FepA, FecA from E. coli, FptA and FpvA from P.
aeruginosa, the cobalamins (e.g., cyanocobalamin, vitamin B12) transporter BtuB from E.
coli, and the colicin I receptor Cir from E. coli all belong to this class (Cobessi et al.,
2005). The strands of the β-barrel are connected by extracellular long loops and short 
periplasmic turns as already seen in porins. The N-terminal domain, often referred to as
either the “plug” or “cork” domain, contains mixed four stranded β-sheets connected by a 
series of short β-strands, α-helices and irregular secondary structure elements. This domain 
is situated in the middle of the barrel (Figure 1.3.3.1A).
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Figure 1.3.3.1 Crystal structure of (A) FecA (PDB 1KMP) and (B) FecA in complex with
iron-free dicitrate (PDB 1PO0). The two extracellular loops L7 and L8, which undergo
major conformational changes upon ligand binding, are shown in blue. The plug domain is
colored purple. The switch helix colored orange, located in the periplasmic pocket of
FecA, only observed in the unliganded conformation. The substrate iron-free dicitrate is
shown as yellow spheres.
Siderophores are secreted by bacteria to acquire iron (Ferguson and Deisenhofer, 2002)
and the iron siderophore complex is then transported through the outer membrane. All the
iron-siderophore transporters characterized to date have essentially the same structure. The
A
B
17
barrels are 60-70Å in height and have an elliptical cross section. The transporters can exist
in three states, (I) apo, (II) bound to siderophore and (III) bound to the iron-siderophore
complex. All three binding states have been characterized for FecA (Ferguson et al., 2002;
Yue et al., 2003). Comparison between the unloaded FecA and FecA bound to siderophore
(citrate) reveals only minor differences (~1Å) in the extracellular loops L7 and L8. Major
conformational changes occur when FecA binds the ferric citrate complex, including 10Å
movements in the two extracellular loops L7 and L8. Conformational changes also occur in
the plug domain and an N-terminal segment inside the periplasmic pocket, termed the
‘switch helix’. The helix is thought to unwind and become disordered (Figure 1.3.3.1B).
Structures of FhuA and FhuA - iron-ferrichrome complex have been reported by two
independent groups (Ferguson et al., 1998; Locher et al., 1998). The barrel domain and the
extracellular loops undergo only minor changes and the key differences lie in the plug
domain and the ‘switch helix’. Upon ligand binding, the plug domain is translated upward
towards the ligand and the switch helix is completely unwound and rotated ~180° in the
opposite direction of the former helix axis (Ferguson et al., 1998).
Compared to the structures of iron-siderophore transporters, BtuB and Cir have shorter
transmembrane barrels with BtuB around 55Å and Cir around 40Å. In general these
structures possess shorter extracellular loops, except that in Cir loops L7 and L8 are very
long (Buchanan et al., 2007). Upon binding its substrate colicin Ia, Cir undergoes some
conformational changes by moving its extracellular loops L7 and L8 as a rigid body. The
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conformation became more open compared with the uncomplexed Cir structure (Figure
1.3.3.2) (Buchanan et al., 2007).
Figure 1.3.3.2 Conformational changes in Cir upon ligand binding. A superposition of
uncomplexed Cir (PDB code: 2HDF) and colicin-bound Cir (PDB code: 2HDI) shows that
the most significant change occurs in the extracellular loops L7 and L8. These loops are
colored green in the apo Cir and orange in the Cir-colicin complex.
When BtuB binds the cyanocobalamin, small conformational changes occur in several
extracellular loops and once again large changes can be observed in the plug domain. The
Ton box, a highly conserved stretch of seven amino acid residues near the N-terminus of
TonB-dependent transporters (Chimento et al., 2003) also undergoes change. Interestingly
the conformational change in FhuA upon binding TonB is relatively minor (Pawelek et al.,
2006) whilst the conformation of Ton box in BtuB-TonB complex is significant (Shultis et
al., 2006). In all structures to date, the plug domain obstructs the channel therefore
19
conformational change of the luminal domain is required for to create a path for substrate.
The nature of this change is not known.
1.3.4 Monomeric β-barrel proteins 
OmpA, OmpX, OmpW, PagP from E. coli, and NspA from Neisseria meningitides all
belong to the same 8 β-stranded barrel family (Figure 1.3.4.1). The basic architecture 
comprising of long extracellular loops and short periplasmic turns is again found in these
proteins. However, there are important differences: PagP has a periplasmic N-terminal
amphipathic α-helix (Figure 1.3.4.1d) and the interior of the OmpW barrel is a 
hydrophobic channel possibly involved in the transport of small hydrophobic molecules
(Hong et al., 2006). Inside OmpA, OmpX and NspA, there is an extensive
hydrogen-bonding network but no channel through which ions or other molecules could be
transported (Pautsch and Schulz, 1998; Vandeputte-Rutten et al., 2003; Vogt and Schulz,
1999). PagP has an unusual interior: the hydrophobic upper half devoid of waters and the
hydrophilic lower half with polar side chains (Ahn et al., 2004).
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Figure 1.3.4.1 A gallery of 8-stranded β-barrel proteins. (a) OmpA (PDB code: 1BXW) 
(b) OmpX (PDB code: 1QJ8), (c) OmpW (PDB code: 2F1V), (d) PagP (PDB code:
1THQ), (e) NspA (PDB code: 1P4T).
Currently, there are only two outer membrane proteins with 10-strands have been
structurally characterized. One is the protease OmpT from E. coli (Vandeputte-Rutten et
al., 2001) and the other is adhesin OpcA from Neisseria meningitides (Prince et al., 2002).
A comparison of these two structures showed that the overall fold was similar: a long
transmembrane β-barrel that protrudes far from the lipid bilayer into the extracellular space 
(Figure 1.3.4.2). The top of OmpT barrel is circular whereas in the central part of the
molecule is elliptical. In contrast, the OpcA barrel has an elliptical cross section along its
a b c
ed
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barrel axis. Both barrels are apparently accessible to water from the periplasmic side, but
both are blocked on the extracellular face.
Twelve-stranded b-barrel membrane proteins have also been reported. These include the E.
coli nucleoside transporter Tsx (Basle et al., 2004) and the N. meningitides autotransporter
NalP β-domain (Oomen et al., 2004), which has an additional α-helical peptide (Figure 
1.3.4.3A) in the middle. The autotransporter EspP from E. coli has a similar structure as
NalP (Barnard et al., 2007) but unlike NalP, the β-domain of EspP begins with a short 
A
B
Figure 1.3.4.2 Structures of OmpT (PDB
code: 1I78) and OpcA (PDB code: 1K24). (A)
Side view of OmpT with 90 degree turn with
respect to each other. (B) Side view of OpcA
with 90 degree turn with respect to each other.
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α-helix. However, it is predicted that full length EspP contains an amphipathic α-helix 
spanning the length of the barrel pore as seen in NalP (Barnard et al., 2007). The
autotransporter Hia from Haemophilus influenzae is a 12-stranded β-barrel domain 
superficially similar to that in NalP (Meng et al., 2006). Strikingly in Hia the barrel is
assembled by three subunits with each contributing four β-strands. Three α-helices, one 
from each subunit, fill the central pore (Figure 1.3.4.3B). This is radically different from
other bacterial outer membrane proteins discussed thus far whose barrels are typically
formed from a single monomer.
Figure 1.3.4.3 Structure of the β-domain from NalP (PDB code: 1UYN) and Hia (PDB 
code: 2GRB). (A) Side view of β-domain of NalP, the N-terminal α-helix is colored red. 
(B) Side view of Hia β-domain, each subunit is colored in a different color. 
A B
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This multi subunit single barrel is also found in TolC (Koronakis et al., 2000), VceC
(Federici et al., 2005), OprM (Akama et al., 2004), MspA (Faller et al., 2004) and
α-haemolysin (Song et al., 1996). Although very different in sequence, E. coli TolC, V.
cholerae VceC and P. aeruginosa OprM share a high degree of structural similarity. They
have a 12 stranded β-barrel that is anchored to the outer membrane and is attached to a 
long α-helical periplasmic barrel. Both barrels are formed from three protomers (Figure 
1.3.4.4). The β-barrel is completely open in TolC, while in both OprM and VceC three 
extracellular loops form a constriction. The α-helical barrel is closed at the periplasmic end 
in all three proteins and is assumed to represent a “resting state”. As these three proteins
are responsible for the export of drugs and other toxic compounds from the cytoplasm
(Federici et al., 2005) the periplasmic domain must open during function.
α-haemolysin is assembled from seven subunits to form a 14 β-stranded barrel with a large 
extracellular domain shaped like a mushroom with a large central hydrophilic channel
(Figure 1.3.4.4B). MspA from Mycobaterium smegmatis has a 16-stranded β-barrel formed 
from eight subunits (two stands per protomer) (Faller et al., 2004).
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Figure 1.3.4.4 Structure of TolC (PDB code: 1EK9) and α-haemolysin (PDB code: 7AHL). 
(A)the three TolC subunits are colored differently.. (B) In the structure of α-haemolysin, 
one subunit is colored purple. The approximate position of the outer membrane (O), the
extracellular side (E) and the periplasmic side (P) are indicated.
OmpG is a single protomer and is 14-stranded β-barrel functioning as a porin. OmpG has a 
large channel and lacks the constriction zone seen in other porins (Subbarao and van den
Berg, 2006; Yildiz et al., 2006). Instead, OmpG has flexible extracellular loops which
undergo conformational changes under different pH conditions. At neutral pH the pore is
open (Figure 1.3.4.5A) but at pH 5.6 (or lower) the pore is blocked by loop L6 which folds
across and into the channel (Figure 1.3.4.5B).
A B
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Figure 1.3.4.5 Structure of OmpG in two conformation states viewed from the extracellular
side of the membrane. Loop L6 which undergoes largest conformational change is labeled.
(A) Open conformation of OmpG (PDB code: 2IWV). (B) Closed conformation of OmpG
(PDB code: 2IWW).
The fatty acid transporter FadL from E. coli (van den Berg et al., 2004), the aromatic
hydrocarbon transporter TodX from Pseudomonas putida and TbuX from Ralstonia
pickettii (Hearn et al., 2008) have a similar 14 β-stranded barrel. In each structure the 
lumen occluded by an N-terminal “hatch domain” consisting of three short helices. The L3
consists of two antiparallel α-helices which forms a hydrophobic cleft that is thought to 
bind substrate. In TodX and TbuX, the loop lies flat on the top of the barrel while in FadL
it protrudes into the extracellular environment (Figure 1.3.4.6). Based on structural data, a
model has emerged in which substrate is bound by the extracellular loop L3 before transit
into the central hydrophobic channel. A conformational change of the hatch domain allows
substrate to diffuse into the periplasm.
L6 L6
A B
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Figure 1.3.4.6 Structure features of TodX (A, PDB code: 3BSO) and FadL (B, PDB code:
1T16). The N-terminal hatch domain is colored in purple, the extracellular loop L3 is in
blue. The position of outer membrane (O), the extracellular side (E) and the periplasm (P)
are indicated.
As has been seen despite the variability, the dominant feature of outer membrane proteins
is the β-barrel architecture. β-barrel proteins are transported and assembled by a specialised 
protein transport machinery involving multiple proteins (Kim et al., 2007). The outer
membrane protein 85-two-partner secretion B (Omp85-TpsB) superfamily is at the heart of
this system. Omp85-TpsB is thought to contain a C-terminal β-barrel region and an 
N-terminal region with putative polypeptide-transport-associated (PORTA) domains
(Clantin et al., 2007). FhaC, an outer membrane protein from the Omp85-TpsB transporter
family, plays a role in the secretion of filamentous hemagglutinin (FHA) from Bordetella
pertussis (Clantin et al., 2007). FhaC is a monomer comprising of a 16 stranded β-barrel 
A B
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with the loop L6 forming a hairpin inserted into the barrel. The extracellular N-terminus of
the protein is a long α-helix (H1), and this helix spans through the transmembrane β-barrel. 
The helix connects to a periplasmic module that precedes the β-barrel. The periplasmic 
module consists of two structurally related PORTA domains. The domains, both 75
residues with the same topology of strand-helix-strand-strand, consist of a three-stranded
β-sheets and one α-helix (Figure 1.3.4.7). The two domains are thought to recognize the 
N-terminus of FHA, providing a template for assembly and export. Translocation is
proposed to start with FHA which adopts an extended β-hairpin structure during transit 
which refolds at the cell surface. After the C-terminus of FHA has reached the cell surface,
the N-terminus of FHA dissociates from PORTA1 and completes translocation (Clantin et
al., 2007). This templating function of the POTRA domains is predicted to be the basis by
which β-barrels themselves are formed. A stretch of amino acids in the unfolded protein 
binds to the POTRA domain creating the first β-strand against which the other strands of 
the protein assemble. This process once started is presumably spontaneous. The β-barrel 
structure is extremely strong, being held together by extensive main chain hydrogen bonds.
In fact many β-barrels can be removed from the membrane by very harsh detergents 
without unfolding, they are relatively insensitive (at least in the membrane portion) to
proteases and can be handled quite harshly during purification (precipitation for example).
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Figure 1.3.4.7 Structure of FhaC (PDB code: 2QDZ). The α-helix H1 is colored red, 
PORTA 1 yellow, PORTA 2 blue, loop L6 in olive.
1.3.5 α-helix outer membrane protein 
Until recently all outer membrane proteins were presumed to follow the β-barrel paradigm 
and POTRA templating system provided a simple rationale for this. The structure of Wza
showed this not to be the case, it has an α-helical barrel which spans the outer membrane 
(Dong et al., 2006). Wza is assembled from eight protomers with a very large central
periplasmic cavity (reminiscent of TolC) (Figure 1.3.5.1). Although the α-helical barrel is 
completely open, the central cavity is closed to the periplasm. Creating an opening into this
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central cavity would seem essential for function but the trigger for any such opening is
unknown.
Figure 1.3.5.1 Structure of Wza (PDB code: 2J58). (A) Side view of Wza. The outer
membrane (OM) position is marked. (B) The channel of Wza, viewed from outside of the
cell.
The structure of Cytolysin A (ClyA) from E. coli K12 at its membrane state (Mueller et al.,
2009) is the second example of α-helical outer membrane proteins. ClyA is a pore forming 
toxin (PFT). PFTs are produced as soluble proteins by their host organisms and can
transform into the membrane integrated state (Parker and Feil, 2005). PFTs are of two
kinds: α-PFTs or β-PFTs, depending on their types of pores integrated into the membrane 
A BOM
30
(Gouaux, 1997). The structure of ClyA is of cylinder shape comprised by 12 α-helical 
protomers (Mueller et al., 2009) (Figure 1.3.5.2). The crystal structure of ClyA in the
membrane state is different from its soluble state, indicating an extensive conformational
change have to take place (Mueller et al., 2009).
Figure 1.3.5.2 Structure of ClyA (PDB code: 2WCD). View from top (left). View from
side (middle). The outer membrane (OM) position is marked. View from bottom (right).
One protomer is colored magenta and the rest are green.
O
M
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Chapter 2
The role of OmpC porin mutants in clinical
drug resistance
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Summary
Clinical (as opposed to laboratory) antibiotic resistance is a complex process in which
numerous factors contribute. The clinical strains referred to in this study, were isolated
from a patient with an E. coli infection of liver cysts and suffering from Caroli Syndrome
(Low et al., 2001). The patient was treated by a variety of antibiotics over a period of four
years from December 1994. The clinical strains, isolated from the last two years of the
patient’s life, progressively exhibited greater antibiotic resistance in which the last isolate
showed resistance to a broad spectrum of antibiotic (Low et al., 2001). The later isolates all
evolved from the first single focal infection with an E. coli strain which was deficient in
OmpF expression and carried a unique ompC gene (OmpC20). While deciphering each
factor that contributed to antibiotic resistance would be beyond the scope of our study, we
wished to determine the role of OmpC mutants in the antibiotic resistance. We carried out
the MTT assay in which a control strain of E. coli lacking OmpC was transformed with
OmpC20 (isolated from the antibiotic sensitive strain) and OmpC33 (isolated from the
antibiotic resistant strain) and their ability to uptake antibiotics was compared. Results
suggested that OmpC does make contributions to the clinical antibiotic resistance.
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2.1 Introduction
2.1.1 β-lactam antibiotics  
Antimicrobial compounds are considered one of the most significant discoveries of the 20th
century. They have been in wide application since the 1940’s after Alexander Fleming
discovered penicillin in 1920’s. Ever since then, different antibiotics have been discovered
and developed and they fall into several different classes, the most common of which are
described below.
The β-lactam class are the most frequently used antibiotics in clinical practice and account 
for about 50% of antibiotic use world-wide (Livermore, 1998). β-lactam antibiotics can be 
divided into groups according to their chemical structure. They share the common
structural feature of the four-membered β-lactam (azetidin-2-one) ring. The β-lactam class 
includes the penicillins and cephalosporins. Penicillins are N-acylated derivatives of
6-β-amino penicillanic acid as shown in figure 2.1.1.1. The basic structure of penicillins is 
a tripeptide intermediate which can be synthesed by two amino acids: valine and cysteine.
The third amino acid (R in the diagram) of this tripeptide confers the diversity of
penicillins and it also gives specific properties on different types of penicillins.
34
Figure 2.1.1.1 Molecular structures of some penicillin antibiotics (Diagram adapted from
website http://helios.bto.ed.ac.uk/bto/microbes/penicill.htm).
Cephalosporins are N-acylated derivatives of 7-β-aminocephalosporanic acid. These 
compounds have the β-lactam ring fused to a 6-membered dihydrothiazine ring containing 
sulphur and a double bond (Figure 2.1.1.2). Two sites (marked as R and X in the diagram)
can be modified, giving rise to a huge number of semi-synthetic derivatives.
Cephalosporins are grouped into a series of generations (Babic et al., 2006). Early
compounds such as cephaloridine are defined as the first generation; compounds resistant
to β-lactamases such as cefuroxime are the second generation and compounds not only 
resistant to β-lactamases but also with enhanced antibacterial activity, such as cefotaxime, 
are the third generation cephalosporins. More recently, fourth and fifth generation
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cephalosporins have been recognized and described (Babic et al., 2006). The newer
cephalosporins generations have more enhanced Gram-negative antimicrobial abilities.
Figure 2.1.1.2 Structure of cephalosporin antibiotics. (a) cephalosporin backbone.
(b) cephaloridine. (c) cefuroxime. (d) cefotaxime.
(a) (b)
(c)
(d)
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2.1.2 Antibiotic resistance
At the early days of antibiotic application, due to the effectiveness of the antibiotics,
various bacterial diseases were considered to be defeated (Kumar and Schweizer, 2005).
However, the widespread use and misuse of antibiotics has selected antibiotic-resistant
pathogens, including the multi-drug resistant strains (Levy, 1998; Neu, 1992). These
resistant bacteria are of two kinds: opportunistic and professional (Neu, 1992). These
bacteria make use of a variety of ways to combat with antibiotics. They can degrade the
drug, inactivate the drug by enzymatic modification, or alter the drug target (Davies,
1994). The resistance of Gram-negative bacteria to the β-lactam is a combination of 
β-lactamases, outer membrane permeability and efflux systems (Babic et al., 2006; Kumar 
and Schweizer, 2005; Lambert, 2005).
In Gram-negative bacteria, one important mechanism of resistance is the inactivation of
β-lactam antibiotics by periplasmic enzymes called β-lactamases (Massova and 
Mobashery, 1998). Beta-lactamases are proposed to be descended from cell wall
biosynthetic enzymes, the so-called penicillin-binding proteins (PBPs) (Medeiros et al.,
1987). PBPs are present on the surface of the cytoplasmic membrane in almost all bacteria
and they are essential enzymes that catalyze the peptidoglycan synthesis process. The
structures of β-lactams are similar to one of the subunits that comprise peptidoglycan; 
therefore when PBPs use penicillin as the substrate mistakenly for cell wall synthesis, the
following steps in cell wall synthesis are hindered and eventually bacteria killed (Babic et
al., 2006). Beta-lactamases hydrolyze the β-lactam ring and inactivate the antibiotic before 
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it reaches the PBP target. The structural closeness between β-lactamases and PBPs allows 
β-lactamases to hydrolyze and inactivate the β-lactam (Massova and Mobashery, 1998). 
The permeation of antibiotics through the outer membrane of Gram-negative bacteria is
largely governed by porins (Nikaido, 2003) and altered porin properties have been
observed in many drug resistant bacteria (reviewed in (Pages et al., 2008). It has been
shown that loss of porin in K. pnuemoniae confers resistance to cephalothin and
cefotaxime (Chevalier et al., 2000). Several studies reported the alteration of porin patterns
contribute to the exclusion of antibiotics. In K. pnuemoniae strains highly resistant to a
number of cephalosporins, there is an expression shift: the narrower-channel porin,
OmpK36 (an OmpC homolog) is expressed in favor of the larger-channel porin, OmpK35
(an OmpF homolog) (Hernandez-Alles et al., 1999). It has been shown that E. coli resistant
to certain β-lactam antibiotics have increased OmpC levels at the expense of OmpF, even 
at low osmolarity (Harder et al., 1981). There are also reports on mutations in the
constriction zones in porins from pathogens to confer antibiotic resistance, such as
Enterobacter aetogenes (Thiolas et al., 2004) and Neisseria gonorrhoeae (Olesky et al.,
2002).
Active drug efflux systems in bacteria are believed to be another important mechanism of
resistance. They can be divided into four families on the basis of supermolecular assembly,
mechanism, and sequence homology (Nikaido, 1994a). These are the major facilitator
family (MFS) (Marger and Saier, 1993), small mutidrug resistance family (SMR) (Grinius
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et al., 1992), resistance-nodulation-division family (RND) (Saier et al., 1994), and ABC
[adenosine triphosphate (ATP)-binding cassette] transporters (Nikaido and Saier, 1992).
To pump out drugs, the first three families use a proton-motive force as a source of energy,
whereas the ABC transporters utilize ATP. Some efflux pumps are selective and only
pump out specific antibiotics. However, there are also multi-drug resistance (MDR) pumps
that have the ability to remove a large number of unrelated and structurally diverse drugs
from the cell (Lewis, 1994). It is well known that in Gram-negative bacteria, there are
three-component export systems that contain a transporter which is a cytoplasmic
membrane protein, an outer membrane channel and a periplasmic protein. Such systems
have been identified and include: AcrAB-TolC (Figure 2.1.2.1) (Koronakis, 2003;
Wandersman and Delepelaire, 1990), and mexA-mexB-oprK (Poole et al., 1993).
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Figure 2.1.2.1 Structure of TolC and model of drug efflux. (Left) The structure of the outer
membrane protein TolC. (Right) The drug efflux is achieved by TolC interacting with
AcrA, a membrane fusion protein, and AcrB, an inner membrane efflux transporter (Okusu
et al., 1996) (Picture extracted from Koronakis, 2003).
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2.1.3 MTT assay
MTT assay is one of the colorimetric assays used for measuring the activities of enzymes
reacting with MTT. The key component, MTT, in this system is
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (Figure 2.1.3.1 left). MTT
is one of the tetrazolium salts that have various applications in cell biology (Berridge et al.,
2005). At the core of the tetrazolium structure, four nitrogen atoms form a positively
charged quaternary tetrazole ring (see the structure of MTT in figure 2.1.3.1), and this ring
is usually surrounded by three aromatic groups (Berridge et al., 2005). Tetrazolium salts
are water-soluble, after reduction, their colorless or weakly colored solutions can be
transformed into intensively colored formazan precipitate. The dissolved formazan can be
measured spectrophotometrically and the reaction has become the basis of biochemical
application of tetrazolium salts.
Aqueous solutions of MTT are yellowish in color. Due to the presence of phenyl rings that
provide the hydrophobic properties of the molecule, MTT is able to enter cells readily. It is
believed that MTT is reduced by NAD(P)H-dependent oxidoreductases and
dehydrogenases of metabolically active cells (Berridge et al., 2005). The reduction results
in intracellular insoluble blue-magenta colored formazan crystals (Figure 2.1.3.1 right)
which however can be dissolved in acidified isopropanol resulting in a purple solution
(Denizot and Lang, 1986; Mosmann, 1983). The assay first described by Mosmann was
used to measure cell proliferation and cytotoxicity (Mosmann, 1983). Since then, this essay
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and its modified version have been used extensively to characterize the cell metabolic
activity. The reduction takes place only when the cells are metabolically active; dead cells
do not react with MTT (Berridge et al., 2005; Ulukaya et al., 2008) . Cytotoxic compounds
damage or kill the cells, which result in the reduced ability for the reduction of MTT.
Therefore this reaction is often used as a measure of living cells as higher number of live
cells results in higher amount of MTT formazan hence higher spectrophotometerical
absorbance. When the live cells are treated with an agent, say antibiotics, the resulting
purple formazan can be compared with that produced by the control cells; the effectiveness
of the antibiotics can be deduced from this difference.
Figure 2.1.3.1 Yellow MTT (left) (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide, a tetrazole) can be reduced to purple formazan (right) in living cells.
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2.1.4 Project background
This project has been in collaboration with Professor Ian Booth, University of Aberdeen.
We have chosen to study naturally occurring mutants of the OmpC porin from a clinical E.
coli infection. The OmpC mutants were isolated from a patient with an E. coli infection of
liver cysts and suffering from Caroli Syndrome. The patient was treated by a variety of
antibiotics over a period of four years from December 1994. E. coli isolates were collected,
either from blood samples or directly from liver abscesses over a two year time period
(Low et al., 2001). Measurement of the minimum inhibitory concentrations (MIC) for each
of the antibiotics used during treatment of the patient had shown that the E. coli isolates
had, in general, progressively greater antibiotic resistance (Figure 2.1.4.1). The last isolate
shows broad spectrum antibiotic resistance (Low et al., 2001). The later isolates all evolved
from the first single focal infection with an E. coli strain which was deficient in OmpF
expression and carried a unique ompC gene (OmpC20) (Low et al., 2001). OmpC20 differs
from the “standard” uropathogenic OmpCO6 (Welch et al., 2002) strain at 27 amino acids,
and with an 8 residue deletion in loop L4 and 4 residue deletion in L7 (Figure 2.1.4.2).
There is no data on when or where the changes between OmpCO6 and OmpC20 took place
(may not have been in patient), our study is focused on the change from the first isolate
(antibiotic sensitive containing OmpC20) to the final isolate (antibiotic resistant containing
OmpC33). During the infection, the OmpC gene mutated to OmpC26 (mutation D18E),
then to OmpC28 (additional mutation S271F), and finally to OmpC33 (additional mutation
R124H) (Figure 2.1.4.2). These changes correlate with increase in clinical antibiotic
resistance.
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Figure 2.1.4.1 Antibiotic resistance in the seven isolates (Figure from Low et al., 2001).
The OmpC protein from clinical E. coli strain No. 1, 2 and 3 are denoted as OmpC20,
isolate 4 as OmpC26, isolate 5 as OmpC28 while OmpC33 refers to isolate No.6 and 7.
The antibiotic therapy received by the patient is indicated on a time line below the MIC
table. Filled arrows indicate dates on which the antibiotic combination was changed.
β-lactam antibiotics are indicated in bold. Open arrows indicate when each isolate was 
obtained.
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Figure 2.1.4.2 Sequence Alignment of OmpC from clinical isolates stated in Low et al
2001, and OmpCO6 from uropathogenic E. coli O6:H1 (accession no. Q8CVW1). The
alignment was carried out in Multalin (Corpet, 1988). Above the alignment, the β-strands 
forming the barrel and the extracellular loops connecting the β-strands are numbered. The
β-strands are labeled β1-β16 and β1’, strand β1 from the N-terminal and strand β1’ from 
the C-terminal are two parts of the same strand. The residue numbering is according to that
of OmpCO6.
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Clinical antibiotic resistance is often multifactorial and no single change in any protein can
be said to “cause” its occurrence. In order to investigate the contribution of the OmpC
porins to antibiotic resistance, the wild type ompC gene from E. coli K12 (OmpCK12) was
expressed from the plasmid pOmpCWT in the first (containing OmpC20) and the last
(containing OmpC33) clinical isolates, respectively. Results showed that in the first
clinical isolate there were no significant differences in MIC in the presence or absence of
OmpCK12. However, the last transformed clinical isolate recovered susceptibility to
antibiotics, particularly for the two carbapenem antibiotics, meropenem and imipenem
(Table 2.1.4.1, courtesy Professor Ian Booth) suggesting that mutations in OmpC33 are in
part responsible for clinical antibiotic resistance.
Table 2.1.4.1. Minimum Inhibitory Concentrations of Antibiotics (µg / ml)
Strain Meropenem Imipenem Ciprofloxacin Cefotaxime Ceftazidime
First clinical
isolate
(OmpC20)
0.062 0.25 1.0 0.5 0.5
First clinical
isolate
(OmpC20),
pOmpCWT
0.031 0.25 1.0 0.125 0.5
Last clinical
isolate
(OmpC33)
2.0 4.0 8.0 32 64
Last clinical
isolate
(OmpC33),
pOmpCWT
0.125 1.0 4.0 16 32
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As the difference between OmpC20 and OmpC33 is only three residues, we wished to
isolate the factor of OmpC porin and determine the role of mutation in the clinically
observed resistance to the antibiotics.
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2.2 Materials and methods
2.2.1 Expression of OmpC
The OmpC expression constructs were made by Professor Ian Booth, our collaborator, at
the University of Aberdeen and Dr. Vicki Bamford who worked as a postdoc in our
laboratory. The plasmid containing the variant OmpC genes were transformed into OmpC
and OmpF minus E. coli HN705 cells (Sugawara and Nikaido, 1992).
The transformed HN705 cell cultures were stored in 10% glycerol at -80ºC. A small
amount of cells were used to inoculate 10mL LB medium containing 30 µg / ml
chloramphenicol and 0.5 % (w/v) glucose for inhibiting the LamB expression. For the
growth of HN705 cells, no antibiotics were added during fermentation. Cells were grown
at 37 °C and were harvested by centrifugation. To check the expression level of OmpC,
10-15µl intact cells were incubated with SDS at 100ºC for 15min and centrifuged to
remove the unsolubilised cells before running the gel. Gels were run at 200V for 35mins in
MES running buffer, pH 7.4, following the manufacturer’s protocols (Invitrogen). Proteins
were stained by Coomassie blue staining. Molecular weight values were estimated from
the migration rates of Mark-12 markers (Invitrogen).
The intensity of the bands corresponding to OmpC protein was analyzed by the software
ImageGauge V4.21. The corresponding bands were sent to Mass-Spec for the identity
check.
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2.2.2 MTT assay without antibiotics
2.2.2.1 Influence of cell numbers and the growth stage
MTT assay were carried out using a modified procedure for the Cell Growth
Determination Kit (Sigma-Aldrich). MTT solution at concentration of 5mg/ml was directly
from the manufacturer Sigma-Aldrich. Other solutions were from the manufacturer or
made fresh in the lab and sterilised using 0.22μm membrane filter. To define the suitable 
concentration of cell culture reacting with MTT, cells at exponential phase (OD600
~1.0)and stationary phase (OD600 ~2.0) were harvested, respectively. Cells were
resuspended in sterilized phosphate buffered saline (PBS, pH 7.4) and were washed three
times with PBS. A series of dilutions were made to give an OD600 value range of 0.1 to 1.0.
The reaction took place at a cuvette (10mm wide) by adding 90 µl of resuspended cells
along with 10 µl 5mg/ml MTT. After incubation for 4 hours at 20 ºC, 900 µl of 0.1N HCl
(~36%, Fisher Scientific) dissolved in absolute isopropanol (99.9%, VWR International)
was added to the cuvette to solubilise the formazans. Pipetting up and down was necessary
to fully solubilise the formazans. The absorbance of each sample was measured at
wavelength of 570 nm with the background absorbance at 690 nm subtracted. The solution
for zeroing the background was 900µl 0.1N HCl dissolved in absolute isopropanol plus
100µl PBS solution. Each cell concentration was measured at least three times within an
independent experiment.
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2.2.2.2 Influence of added MTT amount
To measure the influence of the amount of MTT added to the cell culture, 5μl, 10μl, 15μl 
5mg/ml MTT solution was added to 90μl cell culture, corresponding to ~5%, 10%, ~15% 
of the total reaction volume, respectively. Experiments were carried out triplicate at room
temperature for 4 hours and following the protocol as described above.
2.2.2.3 Influence of cell viability
Cells at an OD600 0.4 were killed by heating at 100 ºC for 1h. 10µl MTT solution was
added to 90µl dead cell solutions and left at room temperature for reaction. MTT activity
was checked by eye-observation after 24 hours.
2.2.2.4 Influence of incubation time with MTT
Cells growing to late exponential stage (OD600 ~1.0) were harvested and washed three
times by PBS. Cells were diluted to give an OD600 0.4. 10µl MTT solution was added to
90µl cell solutions and left at room temperature for reaction for a time period of 1h, 2h, 3h,
4h, 5h, 6h, 7h, 8h and 20h. Reading was recorded as described above.
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2.2.3 MTT assay with antibiotics
2.2.3.1 The influence of antibiotic itself on MTT activity
Three antibiotics, gentamicin sulfate (Melford, UK), carbenicillin disodium (Melford, UK),
cefotaxime sodium (Sigma, Germany) were tested for their reaction with MTT. Antibiotic
solutions were made in PBS as 1M concentration as stock. The solutions were made fresh
on the day of experiment. 10µl 5mg/ml MTT solution was added to 10µl antibiotic
solutions along with 90µl PBS. The final concentration of antibiotics is approximately
100mM. After incubation for 4 hours at 20ºC, 890µl 0.1N HCl dissolved in isopropanol
was added to the solution. Measurement was carried out using the spectrophotometer
which used to measure the MTT activity with cells. The zeroing solution was 890µl 0.1N
HCl dissolved in isopropanol plus 110µl PBS.
2.2.3.2 The control strain E. coli HN705
The metabolic activity of E. coli HN705 (OmpC and OmpF knocked out), was investigated
by the MTT assay. Cells growing to the exponential stage and stationary stage were
harvested, washed and diluted with PBS to give a series of OD value ranging from 0.1 to
1.0. The measurement was taken place as described in section 2.2.2.1.
2.2.3.3 MTT assay with antibiotics
Three antibiotics, gentamicin sulfate (Melford, UK), carbenicillin disodium (Melford, UK),
cefotaxime sodium (Sigma, Germany), were tested for their cytotoxity to the cells of
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HN705 transformed with OmpC20 (HN705-OmpC20) and cells of HN705 with OmpC33
(HN705-OmpC33), respectively. Cells were all grown to OD ~1.0 and harvested by
centrifugation, washed with PBS three times and diluted into OD 0.4. Antibiotics dissolved
in PBS at 1M stock were made fresh on the day of experiment or stored at -20ºC for future
use.
We first tested a big range of antibiotic concentrations then zoom into a smaller scale for
further tests. A series of 10µl antibiotic solutions along with 10µl 5mg/ml MTT were
added to 90µl of resuspended cells. After 4 hours incubation at 20ºC the cells containing
the resulting purple crystals were resuspended by addition of 890 µl of 0.1N HCl dissolved
in isopropanol. The absorbance of each assay was measured at wavelength of 570 nm with
the background absorbance at 690 nm subtracted. Each assay was performed at least with
two independent experiments with each sample triplicate. The metabolic activity of cells
without the addition of antibiotics was defined as 100%. After incubation with antibiotics,
the metabolic activity of cells decreased. The metabolic inhibition rate is defined as the
ratio of the amount of cell death to the total number of live cells. It is calculated from the
570nm absorbance mean value. For example, the mean value of 570nm absorbance of cells
without any antibiotics is 0.8, the 570nm absorbance value of cells incubated with 25mM
carbenicillin is 0.3, then by definition, the metabolic inhibition is (0.8-0.3)/0.8 *100%=
62.5%.
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2.3 Results
2.3.1 OmpC expression
HN705 cells, the strain with ompF and ompC knocked out, was grown at the same LB
medium as that for OmpC20 and OmpC33 cells but without antibiotics and glucose.
HN705 cells were used as a control for the OmpC expression. Figure 2.3.1.1 shows the
result of whole cell SDS-PAGE. It shows OmpC20 and OmpC33 are both expressed
(indicated by the pointing arrow) with no significant difference on the expression level.
Analysis by ImageGauge confirmed this observation with corresponding gel bands the
same UV absorbance (indicated by the numbers listed). It is noticed that HN705 cells have
a different expression pattern except for the OmpC protein (figure 2.3.1.1). The OmpC
identity was confirmed by Mass-spec peptide mapping (data not shown).
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Figure 2.3.1.1 Comparison of expression level of OmpC20 and OmpC33 in HN705. Whole
cells in two different batches were solubilized and analysed in separate gels (left, right).
The lanes are marked as shown above the gel. The arrow indicates the location of OmpC
which is absent in HN705 cells. The intensity of the corresponding bands were analysed by
the software ImageGauge and the UV absorbance value was indicated.
1714279
1712703
1985784
1992528
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2.3.2 MTT assay without antibiotics
2.3.2.1 Influence of cell numbers and growth stage
With a defined concentration, MTT must have a maximum ability to act on the cells. To
find out the suitable cell concentration, a series of dilution from the concentrated cell
culture were made and tested. Table 2.3.2.1a shows the MTT formazan absorbance from
OmpC20 and OmpC33 exponential stage cells. Each reaction carried out at individual
cuvette, the measured value at 570nm subtracting the measured value at 690nm is to
exclude the difference factor of cuvette absorbance. It was noticed that at 690nm the
absorbance value were negative, this was because the zeroing solution had a higher
absorbance at 690nm. We define real 570nm absorbance value by the following equation:
Real 570nm absorbance = Measured 570nm absorbance – measured 690nm absorbance
We plotted the real 570nm absorbance against the cell OD600 values. Figure 2.3.2.1a shows
the effect of cell numbers on the 570nm absorbance corresponding to the MTT reduction
activity. It suggests before OD600 0.4, the cell number dominates while after OD600 0.4,
MTT reaches its saturation level as a higher number of cells do not result in relatively
higher activity.
In a similar manner, Table 2.3.2.1b shows the absorbance measured for OmpC20 and
OmpC33 cells harvested from the stationary phase. Figure 2.3.2.1b showed a similar trend
of 570nm absorbance values verses the cell numbers. The two independent experiments
conclude that the best cell concentration reacting with 10μl 5mg/ml MTT is at OD600 0.4.
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Table 2.3.2.1a Absorbance values for exponential stage OmpC20 and OmpC33 cells at varied concentration.
OmpC20
OD600
value 570nm 690nm 570-690nm
570-690nm
mean error
0.1 0.157 0.158 0.158 -0.113 -0.108 -0.11 0.27 0.266 0.268 0.268 0.001
0.2 0.397 0.424 0.363 -0.073 -0.067 -0.11 0.47 0.491 0.473 0.478 0.006
0.3 0.513 0.525 0.489 -0.101 -0.065 -0.08 0.614 0.59 0.569 0.591 0.013
0.4 0.519 0.52 0.493 -0.062 -0.056 -0.074 0.581 0.576 0.567 0.574 0.004
0.5 0.467 0.452 0.463 -0.082 -0.096 -0.084 0.549 0.548 0.547 0.548 0.001
0.6 0.443 0.464 0.41 -0.078 -0.063 -0.099 0.521 0.527 0.509 0.519 0.005
0.7 0.448 0.454 0.41 -0.06 -0.078 -0.078 0.508 0.532 0.488 0.509 0.012
0.8 0.486 0.439 0.367 -0.046 -0.057 -0.074 0.532 0.496 0.441 0.489 0.026
1 0.474 0.458 0.476 -0.066 -0.073 -0.061 0.54 0.531 0.537 0.536 0.003
OmpC33
OD600
value 570nm 690nm 570-690nm
570-690nm
mean error
0.1 0.147 0.172 0.136 -0.094 -0.078 -0.106 0.241 0.25 0.242 0.244 0.003
0.2 0.383 0.317 0.352 -0.091 -0.111 -0.066 0.474 0.428 0.418 0.440 0.017
0.3 0.55 0.523 0.544 -0.089 -0.095 -0.081 0.639 0.618 0.625 0.627 0.006
0.4 0.556 0.599 0.604 -0.091 -0.088 -0.082 0.647 0.687 0.686 0.673 0.013
0.5 0.621 0.625 0.653 -0.046 -0.058 -0.061 0.667 0.683 0.714 0.688 0.014
0.6 0.63 0.598 0.645 -0.058 -0.086 -0.058 0.688 0.684 0.703 0.691 0.006
0.7 0.622 0.687 0.653 -0.081 0.011 -0.058 0.703 0.676 0.711 0.696 0.010
0.8 0.634 0.632 0.626 -0.048 -0.047 -0.065 0.682 0.679 0.691 0.684 0.004
1 0.638 0.59 0.591 -0.063 -0.055 -0.06 0.701 0.645 0.651 0.665 0.018
56
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
OD value
A
bs
or
ba
nc
e
57
0n
m
OmpC20 OmpC33
Figure 2.3.2.1a Influence of cell numbers on the absorbance measurement. OmpC20 and
OmpC33 cells were growing at identical conditions to exponential phase (OD600 ~1.0).
Sample was triplicate and standard (ST) error was indicated.
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OmpC20
OD600
value 570nm 690nm 570-690nm
570-690nm
mean error
0.1 0.044 0.059 0.033 -0.057 -0.037 -0.062 0.101 0.096 0.095 0.097 0.002
0.2 0.088 0.089 0.069 -0.05 -0.045 -0.067 0.138 0.134 0.136 0.136 0.001
0.3 0.11 0.122 0.118 -0.042 -0.048 -0.048 0.152 0.17 0.166 0.162 0.005
0.4 0.157 0.136 0.16 -0.044 -0.041 -0.02 0.201 0.177 0.18 0.186 0.007
0.5 0.163 0.16 0.175 -0.007 -0.021 -0.008 0.17 0.181 0.183 0.178 0.004
0.6 0.154 0.189 0.191 -0.003 -0.003 0.001 0.157 0.192 0.19 0.179 0.011
0.7 0.148 0.144 0.169 -0.02 -0.036 0.003 0.168 0.18 0.166 0.171 0.004
0.8 0.16 0.172 0.167 -0.022 -0.008 -0.011 0.182 0.18 0.178 0.18 0.001
1 0.351 0.305 0.3 0.061 0.017 -0.001 0.29 0.288 0.301 0.293 0.004
OmpC33
OD600
value 570nm 690nm 570-690nm
570-690nm
mean error
0.1 0.098 0.087 0.112 -0.035 -0.06 -0.03 0.133 0.147 0.142 0.141 0.004
0.2 0.169 0.178 0.191 -0.046 -0.045 -0.023 0.215 0.223 0.214 0.217 0.002
0.3 0.249 0.249 0.274 -0.043 -0.043 -0.015 0.292 0.292 0.289 0.291 0.001
0.4 0.425 0.442 0.415 -0.004 0.002 -0.024 0.429 0.44 0.439 0.436 0.003
0.5 0.388 0.417 0.436 -0.041 -0.024 -0.01 0.429 0.441 0.446 0.438 0.005
0.6 0.425 0.426 0.427 -0.038 -0.014 -0.015 0.463 0.44 0.442 0.448 0.007
0.7 0.433 0.432 0.509 0.015 -0.009 0.019 0.418 0.441 0.49 0.449 0.021
0.8 0.422 0.433 0.433 -0.011 -0.002 -0.007 0.433 0.435 0.44 0.436 0.002
1 0.435 0.451 0.466 0.005 0.029 0.032 0.43 0.422 0.434 0.428 0.003
Table 2.3.2.1b Absorbance values for stationary phase OmpC20 and OmpC33 cells at varied concentration.
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Figure 2.3.2.1b Influence of cell numbers on the absorbance measurement. OmpC20 and
OmpC33 cells were grown at identical conditions to stationary phase. Experiments were
done at least three times and standard error indicated.
It was noticed that cells at exponential stage have higher MTT activity than those from
stationary phase, both for OmpC20 and OmpC33. During exponential stage, these two
types of cells had similar activity, while at stationary stage, OmpC33 cells had higher
activity than OmpC20 cells.
2.3.2.2 Influence of MTT amount
With a defined cell numbers, the influence of MTT amount added to the cell culture was
studied with OmpC20 and OmpC33 cells grown to the exponential stage. Table 2.3.2.2
shows the absorbance value with different OD600 values when three different MTT
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amounts were added to the solution. Figure 2.3.2.2 shows the results for OmpC20 and
OmpC33 cells with three different OD600 values 0.3, 0.4, 0.5, respectively. It is shown that
MTT added at a scale of 10% of the total solution (10μl) has its optimum activity with the 
cells. At a scale of 5% MTT (5μl) added to the cell culture at OD600 0.3, 0.4, 0.5, the
measured metabolic activity remained the same even though the cell numbers varied that
varied metabolic activities would be expected. This implied that at this low MTT
concentration all the MTT is consumed only by a portion of live cells, therefore at this
MTT concentration, the metabolic activity does not correlate to the true cell numbers.
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Table 2.3.2.2 Influence of added MTT amount to the absorbance measurement. Cells were harvested from the exponential
growth stage.
OmpC20
OD600
value
MTT
5mg/ml 570nm 690nm 570-690nm
570-690nm
mean error
0.3 5ul 0.203 0.151 0.134 -0.051 -0.085 -0.07 0.254 0.236 0.204 0.231 0.014
0.4 5ul 0.13 0.131 0.063 -0.089 -0.088 -0.093 0.219 0.219 0.156 0.198 0.021
0.5 5ul 0.121 0.122 0.092 -0.096 -0.07 -0.074 0.217 0.192 0.166 0.191 0.014
0.3 10ul 0.48 0.491 0.49 -0.064 -0.091 -0.076 0.544 0.582 0.566 0.564 0.011
0.4 10ul 0.577 0.509 0.638 -0.082 -0.096 -0.067 0.659 0.605 0.705 0.656 0.028
0.5 10ul 0.669 0.741 0.625 -0.092 -0.044 -0.063 0.761 0.785 0.688 0.744 0.029
0.3 15ul 0.493 0.515 0.52 -0.054 -0.059 -0.066 0.547 0.574 0.586 0.569 0.011
0.4 15ul 0.697 0.731 0.709 -0.077 -0.068 -0.073 0.774 0.799 0.782 0.785 0.007
0.5 15ul 0.915 0.93 1.003 -0.037 -0.044 -0.053 0.952 0.974 1.056 0.994 0.031
OmpC33
OD600
value
MTT
5mg/ml 570nm 690nm 570-690nm
570nm-690nm
mean Error
0.3 5ul 0.337 0.311 0.338 -0.085 -0.102 -0.078 0.422 0.413 0.416 0.417 0.002
0.4 5ul 0.37 0.347 0.359 -0.052 -0.057 -0.055 0.422 0.404 0.414 0.413 0.005
0.5 5ul 0.334 0.393 0.427 -0.083 -0.087 -0.058 0.417 0.48 0.485 0.460 0.021
0.3 10ul 0.59 0.58 0.528 -0.097 -0.06 -0.077 0.687 0.64 0.605 0.644 0.023
0.4 10ul 0.68 0.764 0.584 -0.083 -0.086 -0.084 0.763 0.85 0.668 0.760 0.052
0.5 10ul 0.854 0.871 0.904 -0.046 -0.041 -0.054 0.9 0.912 0.958 0.923 0.017
0.3 15ul 0.522 0.572 0.501 -0.077 -0.066 -0.094 0.599 0.638 0.595 0.610 0.013
0.4 15ul 0.618 0.679 0.768 -0.085 -0.078 -0.082 0.703 0.757 0.85 0.77 0.042
0.5 15ul 0.815 0.941 0.946 -0.094 -0.039 -0.064 0.909 0.98 1.01 0.966 0.030
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Figure 2.3.2.2 Influence of the amount of MTT added to the cell culture. OmpC20 and
OmpC33 cells were growing to the exponential stage. Cells were diluted to give an OD 0.3,
0.4 and 0.5. MTT solution at the concentration of 5mg/ml was added to the cell solution at
a volume of 5μl, 10μl, 15μl. 
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2.3.2.3 Dead cells do not react with MTT.
No visible reaction took place with the dead cells incubated with MTT after 24 hours.
Figure 2.3.2.5 shows the comparable results of dead cells and live cells incubated with
MTT. It is clear that dead cells do not react with MTT as no visible color change of the
solution.
Figure 2.3.2.3 The difference of live cells (bottom layer) and dead cells (top layer) reacting
with MTT. Live cells reacted with MTT resulting blue-magenta colored formazan. Dead
cells did not react with MTT as the reaction solution didn’t change the color.
2.3.2.4 Influence of incubation time
It is believed that MTT reduction to its formazan occurs inside the cell (Vistica et al.,
1991). Since the production of formazan would be time-dependent, we wished to examine
the effect of incubation time on the formazan production level. Table 2.3.2.4 shows the
absorbance values measured at different time points. Figure 2.3.2.4 shows that at the first 5
hours of incubation, the MTT formazan production is almost linear like an exponential
Dead cells
Live cells
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stage. After 5-6h of incubation, the MTT formazan production reached its saturation level
as longer incubation time does not result in much higher MTT formazan.
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OmpC20
Incubation
time (h) 570nm 690nm 570-690nm mean ST error
1 0.228 0.232 0.217 -0.028 -0.027 -0.027 0.256 0.259 0.244 0.253 0.004
2 0.493 0.507 0.545 -0.007 -0.004 0.023 0.5 0.511 0.522 0.511 0.006
3 0.697 0.669 0.712 0.052 0.024 0.035 0.645 0.645 0.677 0.655 0.010
4 0.724 0.728 0.768 0.025 0.017 0.017 0.699 0.711 0.751 0.720 0.015
5 0.891 0.902 0.946 0.035 0.066 0.083 0.856 0.836 0.863 0.851 0.008
6 0.864 0.903 0.905 0.024 0.048 0.042 0.84 0.855 0.863 0.852 0.006
7 0.891 0.918 0.903 0.03 0.017 0.032 0.861 0.901 0.871 0.877 0.012
8 0.883 0.906 0.891 -0.012 0.013 0.049 0.895 0.893 0.842 0.876 0.017
20 0.787 0.836 0.874 -0.035 -0.029 -0.028 0.822 0.865 0.902 0.863 0.023
OmpC33
Incubation
time (h) 570nm 690nm 570-690nm mean ST error
1 0.339 0.374 0.342 -0.025 0.005 -0.028 0.364 0.369 0.37 0.367 0.001
2 0.585 0.606 0.57 0.005 0.03 0.01 0.58 0.576 0.56 0.572 0.006
3 0.759 0.777 0.743 0.049 0.05 0.027 0.71 0.727 0.716 0.717 0.004
4 0.873 0.797 0.804 0.053 0.025 0.041 0.82 0.772 0.763 0.785 0.017
5 0.893 0.902 0.847 0.052 0.067 0.025 0.841 0.835 0.822 0.832 0.005
6 0.888 0.865 0.86 0.018 0.046 0.014 0.87 0.819 0.846 0.845 0.014
7 0.916 0.907 0.908 0.025 0.016 0.024 0.891 0.891 0.884 0.888 0.002
8 0.915 0.894 0.886 0.029 0.011 -0.005 0.886 0.883 0.891 0.886 0.002
20 0.876 0.868 0.836 -0.005 -0.008 -0.027 0.881 0.876 0.863 0.873 0.005
Table 2.3.2.4 Influence of incubation time to the absorbance measurement. Cells were harvested from the exponential growth
stage.
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Figure 2.3.2.4 Influence of incubation time on the absorbance measurement of OmpC20
and OmpC33 that were harvested at the exponential stage. Errors were indicated as bars.
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2.3.3 MTT assay with antibiotics
2.3.3.1 The effect of antibiotics on MTT
As a control experiment, we wished to investigate whether the drug itself reacted with
MTT. Within the time of incubation (4h), there was no noticeable change. Table 2.3.3.1
shows the absorbance values measured for the three antibiotics tested. It is seen that the
absorbance value change was minor, therefore the antibiotics have a neglectable effect on
MTT.
Table 2.3.3.1 Effect of antibiotics on MTT
570nm 690nm 570-690nm
Gentamicin 0.134 0.087 0.047
Carbenicillin 0.008 -0.004 0.0120h
Cefotaxime 0.013 -0.002 0.015
Gentamicin 0.093 0.09 0.003
Carbenicillin 0.065 0.039 0.0264h
Cefotaxime 0.02 0.005 0.015
2.3.3.2 The control strain HN705
As shown in figure 2.3.2.3, live cells of HN705 cells also reacted with MTT. This confirms
that MTT can enter HN705 cells via pathway. To further quantify the metabolic activity
of HN705 cells on MTT, the effect of cell numbers and the growth stages of HN705 was
investigated. Figure 2.3.3.2 shows the effect of cell numbers and growth stage on the
570nm absorbance. As with OmpC20/33 cells, the exponential stage cells have higher
activity than those from stationary stage cells. However, it does not show a saturation
concentration with MTT as a higher number of cells result in higher value of absorbance.
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Figure 2.3.3.2 The effect of growth stage and cells numbers on the metabolic activity of
HN705 cells.
2.3.3.3 MTT assay with three antibiotics
The antibiotic concentration was critical as at too high concentrations almost no cells
would be expected to survive and at too low concentrations no cells would die. To verify
this assumption, a series of concentrations for each antibiotic has to be tested to find out
the effective range. Figure 2.3.3.3a shows the effect of antibiotic concentration on the cell
metabolic activities. For all the antibiotics tested, cells have high metabolic activities at
low antibiotics concentrations as the metabolic inhibition is close to zero. The metabolic
inhibition rate increased along with the increase of antibiotic concentrations. In the case of
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gentamicin, very high concentrations (100mM, 200mM) kill the cells as the metabolic
inhibition rate is close to 100%. However, with the case of carbenicllin and cefotaxime,
very high concentration still results in cell metabolic activities. This indicates that the
uptake of these two antibiotics the cells is time-dependent. This initial test give indications
that the effective concentration range for gentamicin was around ~100 μM, for 
carbenicillin was around 50mM, while for cefotaxime was >10mM.
Gentamicin
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OmpC20 OmpC33
OmpC20 0.052714813 0.579862941 46.75803901 100.4744333
OmpC33 0 0 27.4393531 100.754717
0.1uM 1uM 100uM 100mM
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Carbenicillin
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OmpC20 2.852441031 1.206801975 45.91332968 87.27372463
OmpC33 1.394628099 1.239669421 29.64876033 84.76239669
1uM 10uM 50mM 200mM
Cefotaximine
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OmpC20 0.115740741 4.976851852 11.47161066 73.32175926
OmpC33 0.164113786 0.437636761 0.601750547 57.22100656
1mM 5mM 10mM 200mM
Figure 2.3.3.3a The effect of antibiotic concentration on the metabolic activity of HN705
cells expressing OmpC20 and HN705 cells expressing OmpC33. The metabolic inhibition
rate under each antibiotic concentration is listed on the table underneath the figure.
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To further compare the cells’ ability for the uptake of antibiotics, we tested the cells
incubated with a series of intermediate antibiotic concentrations. Figure 2.3.3.3b shows the
extent of metabolic inhibition rate of HN705 expressing OmpC20 and OmpC33 in the
presence of three antibiotics: gentamicin, carbenicillin and cefotaxime, from two
independent experiments. For all the tested antibiotics, HN705 cells expressing OmpC33
showed reproducibly lower metabolic inhibition rate (less antibiotic uptaking) than cells
expressing OmpC20, consistent with other data that shows antibiotic resistance by
OmpC33.
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OmpC20 OmpC33
OmpC20 37.20865 57.62426 54.50716 63.29683 82.25218 88.87953
OmpC33 23.48178 48.35165 59.62984 60.26605 67.37999 85.71429
10uM 50uM 100uM 250uM 500uM 1mM
Gentamicin
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OmpC20 OmpC33
OmpC20 28.72957 43.068 46.75804 47.65419 82.97312 88.92989
OmpC33 6.086957 16.01023 31.1509 33.86189 59.94885 75.24297
10uM 50uM 100uM 250uM 500uM 1mM
(Figure continues)
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Carbenicillin
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OmpC20 20.83998 45.18873 52.57842 67.67677 79.90431 83.25359
OmpC33 15.6911 25.82391 29.31628 34.727 51.50025 61.14117
1mM 5mM 10mM 25mM 50mM 75mM
Carbenicillin
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OmpC20 OmpC33
OmpC20 21.80129 46.39028 63.90279 79.84274 83.98856 84.34596
OmpC33 13.20225 30.67416 33.31461 46.34831 69.66292 75.73034
1mM 10mM 25mM 50mM 75mM 100mM
(Figure continues)
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Cefotaxime
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OmpC20 22.63294 29.76654 46.95201 55.90143 64.98054 67.12062
OmpC33 11.88699 14.81876 20.14925 29.10448 35.8209 43.60341
1mM 10mM 25mM 50mM 75mM 100mM
Cefotaxime
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OmpC20 27.7753401 44.0982887 44.6248355 51.2505485 51.2505485
OmpC33 4.77262494 27.1949572 24.76362 27.8703287 30.2566412
10mM 25mM 50mM 75mM 100mM
Figure 2.3.3.3b. The effect of antibiotic concentration on the metabolic activity of HN705
cells that express OmpC20 and OmpC33 respectively. A bar chart showing the extent of
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metabolic inhibition in HN705 cells expressing OmpC20 and OmpC33 in the presence of
antibiotics as indicated. Error bars are shown at their standard deviations.
2.4 Discussion and future work
The MTT assay has long been applied to test the metabolic activity of live cells since the
first report from Mosmann (Mosmann, 1983). Growing bacterial cells go through several
stages. Namely, lag phase when no obvious cell growth occurs and the metabolic activity is
low; log phase (also termed as exponential phase) when cells are actively reproducing and
the metabolic activity is most intense; stationary phase when the reproduction rate slows
and so does the metabolic activity. After stationary phase, the bacterial cell population
starts to shrink due to lack of nutrients. As the MTT assay measures the integrated
metabolic activities of cells (Berridge et al., 2005), different MTT reduction activity would
be expected from the different growth stage cells. In this study, it is confirmed that cells at
exponential stage are more metabolic active than at stationary stage both for
HN705-OmpC20 and HN705-OmpC33. Under the identical growth conditions, the gross
metabolic activities at the exponential stage are similar for both HN705-OmpC20 and
HN705-OmpC33 cells as the MTT formazan production are nearly identical. This indicates
that the mutations on OmpC do not change the cell metabolic activity.
The MTT assay with antibiotics uses a defined cell line and is designed to isolate the
changes in OmpC from other changes that are found in the clinical isolates. The assay
establishes that mutations between OmpC20 and OmpC33 do contribute to increasing
antibiotic resistance. This supports the initial proposal that the mutations in OmpC do alter
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membrane permeability (Low et al., 2001). OmpC33, the last mutant to be isolated clearly
restricts the uptake of antibiotics when compared to OmpC20. The clear cut nature of this
result is surprising since there are only three residues differences between the proteins. The
concentration of both β-lactams (~mM) is higher than gentamicin (μM) in order to get 
results comparable. This might be because besides the porin pathway, gentamicin also
enters cell via a self-promoted pathway (Delcour, 2003) through the membrane.
Gentamicin therefore kills the cell faster than those two β-lactams.  
Clinical (as opposed to laboratory) antibiotic resistance is a complex process in which
numerous factors contribute. The clinical strains referred to in this study, in addition to
changes in OmpC sequence, exhibited progressively increased levels of β-lactamase 
expression with lower levels of OmpC expression (Low et al., 2001). Translocation across
the outer membrane is the first and crucial step for Gram-negative bacteriocidal activity for
any antibiotic. Many, but not all, antibiotics enter the cell via the outer membrane porin
family which are responsible for small ion and nutrient flow though the outer membrane.
Bacteria with multiple porin species may have an ecological advantage; loss of only one
porin would allow the other porins to compensate in terms of nutrient flow but would
remove the target site for phages and colicins (Harder et al., 1981; Pugsley and
Schnaitman, 1978). The clinical strains here studied lack OmpF therefore OmpC would
serve as the major routes for the uptake of essential nutrients.
Although the role of outer membrane proteins in antibiotic resistance has long been known,
the molecular basis of mutations that occur in the clinic has not been addressed
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previously.The simplest method of blocking antibiotic transport is to either delete the pore
or render it non-functional. One can speculate that this is because having lost OmpF, the
bacteria need to keep OmpC functional. For the future work, detailed structure information
would help understand the molecular basis for the antibiotics resistance (which will be
discussed in the next chapter). The data of MTT with antibiotics could be further solidified
with HN705 untransformed cells and HN705 cells transformed with OmpCO6 as controls.
Preliminary trials with HN705 untransformed cells growing in LB medium showed they
have much lower inhibition rate to the antibiotics especially the two β-lactams (Figure 
2.4.1). However, these HN705 untransformed cells were growing in LB medium without
glucose supplement. It was noticed earlier that glucose does influence the protein
expression on all the cells in this study (Figure 2.4.2) and in turn, it might influence the
metabolic activity of the cells. The cells show a similar protein expression pattern when the
growth conditions are identical. Since the cells of HN705-OmpC20 and HN705-OmpC33
were grown with glucose, the data of HN705 untransformed cells grown without glucose
might not be valid as a real control. Cells of untransformed HN705 growing with glucose
need to be tested on their antibiotic resistance.
77
Carbenicillin
0
20
40
60
80
100
Concentration
M
et
ab
ol
ic
in
hi
bi
tio
n
(%
)
HN705
HN705 5.39832285 5.81761006 15.5660377 39.4654088 76.9916143
1mM 10mM 50mM 100mM 200mM
Cefotaxime
0
20
40
60
80
100
Concentration
M
et
ab
ol
ic
in
hi
bi
tio
n
(%
)
HN705
HN705 6.65584416 5.10144928 8.87445887 8.92857143 4.54545455
10mM 25mM 50mM 75mM 100mM
Figure 2.4.1 Effect of antibiotic concentration on the metabolic activity of HN705
untranformed cells. The antibiotics are stated. Sample was triplicated and the error bar is
shown.
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Figure 2.4.2 Influence of glucose on the whole cell protein expression of HN705
untransformed cells and HN705 cells expressing OmpC20 and OmpC33, respectively. The
lanes are indicated above: + represents glucose being added in the growth medium, -
represents no glucose added in the growth medium. The position of the target protein
OmpC was indicated by the arrow.
OmpC
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Chapter 3
Crystal structures of clinical OmpC porin
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Summary
This chapter dealt with Gram-negative bacterial outer membrane protein expression,
purification, and crystallization. From the structural information, we wished to understand
how mutations in the porin of a clinically isolated E. coli strain resulted in antibiotic
resistance. Porins were among the first membrane proteins whose structures have been
solved by X-ray crystallography. Porins occur naturally in abundance in the bacterial outer
membrane. This, together with their robust structures made purification and crystallization
relatively easier compared to other membrane proteins.
The structures of the first mutant OmpC20 along with its native type OmpCO6 were solved
by Dr. Vicki Bamford in our lab. Three further OmpC mutants, denoted as OmpC26,
OmpC28 and OmpC33 were solved to 2.28Å, 2.85Å and 3.55Å. The structures of these
mutant proteins provide insights into the molecular mechanism of antibiotic resistance.
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3.1 Materials and methods
3.1.1 Expression and purification of OmpC
The transformed HN705 cell cultures were grown at 310K for 18 hours in Luria-Broth
(LB) containing 30 µg / ml chloramphenicol and 0.5 % (w/v) glucose. The cells were then
pelleted by centrifugation at 6,000g (277K) for 15 mins. The cells were lysed by sonication
in 50mM sodium phosphate, pH 7.5 and 50mM NaCl. The lysate was centrifuged at 100,
000g (277K) for 1 hour to collect the membranes. The disrupted membrane mixtures were
resuspended in 2% (w/v) sodium N-lauroyl sarcosine and incubated at 293K for 2~4 hours
with stirring. This step is to solubilise the inner membrane. The supernatant was
ultracentrifuged (277K) at 100,000g for 1 hour again to collect the outer membranes (OM).
The outer membranes were resuspended in 0.5% (w/v) 3-(N,
N-Dimethylmyristyl-ammonio) propanesulfonate (SB 3.14, Sigma) and incubated
overnight at 293K with stirring. Insoluble materials were removed by centrifugation at
100,000g (277K) for 1 hour.
The supernatant was applied to a POROS-HQ anion exchange column pre-equilibrated
with 50mM sodium phosphate, pH 7.5, 50mM NaCl and 0.025% (w/v) SB3-14. Weakly
bound proteins were eluted with 100mM NaCl before elution of OmpC with 1M NaCl.
Fractions containing OmpC as determined by SDS-PAGE were pooled and diluted into
low salt buffer (salt concentration about 50mM NaCl) in order to bind the protein to the
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column again for detergent exchange to a mixture of 0.6% (w/v)
2-hydroxyethyloctylsulfoxide (HESO) and 0.1% (v/v) n-octylpolyoxyethylene (OPOE), or
1% n-octyl-β-D-glucopyranoside (βOG). Once the proteins were bound to the column, they 
were washed at a low flow rate of 1~5 ml/min with 100ml of the above detergents in
20mM Tris-HCl, pH 8.0. A further step of purification, gel filtration, was applied to
remove the lipids and residual contaminants. The protein was loaded onto a gel filtration
column (Superdex 200, Pharmacia) and eluted in 20 mM Tris-HCl pH 8.0 buffer
containing the above detergents. The elution was performed with one column volume of
20mM Tris-HCl, pH 8.0 together with the detergents used in the last anion exchange step.
The protein eluted as a trimer at around 120 kDa. Fractions containing OmpC were pooled
and concentrated. The protein concentration was determined by UV absorbance using an
extinction coefficient at 280nm of 69920 M-1 cm-1. The theoretical value of extinction
coefficient was obtained from online structure analysis tool
(http://www.expasy.ch/tools/protparam.html). Protein purity was checked at all stages by
SDS-PAGE (Fig. 2.3.1) and mass spectrometry at the end of purification.
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3.1.2 Crystallization of OmpC and optimization
Prior to crystallization experiments, the protein solution was subjected to
ultracentrifugation (100,000g, 1hour, 277K) to remove aggregates. Initial crystallization
trials were performed using the screens MemSys (Molecular Dimensions), MembFac
(Hampton research) and Basic Kit for Membrane Proteins (Sigma). The protein
concentration used for crystallization was 10-14 mg/ml. Sitting drop or hanging drop vapor
diffusion technique was employed throughout the screening and optimization process, with
protein drops of 1~3 µl and a 1:1 ratio of protein: precipitant set up against 100 µl of
reservoir solution. The crystallization trials were set up both at cold room temperature
(4°C) and room temperature (20°C). Crystals with different shapes appeared after a couple
of days with sizes getting larger after up to a month of incubation (Figure 3.1.2.1).
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Figure 3.1.1.1 Coomassie blue stained SDS-PAGE gel of purified
OmpC26 before crystallization. Lane 1 shows the molecular marker
with the corresponding molecular weights (kDa) next to each band.
Lane 2 corresponds to the purified OmpC26, Lane 3 is OmpC26
concentrated 100×more than that in Lane 2. It is shown that OmpC
migrates as a major band at ~38 KDa (monomer) when the samples
are heated in SDS-sample buffer at 373K prior to electrophoresis.
84
Figure 3.1.2.1 Crystal forms of OmpC grown in different crystallization conditions grown
in one week (top two) up to one month (bottom two). From top left clockwise, the crystal
was OmpC26, OmpC28, OmpC28 and OmpC26.
Crystals of OmpC26 were grown optimally using the detergent mixture of 0.6% HESO and
0.1% OPOE at room temperature (20°C). The best crystal of OmpC26 was grown from
0.1M ammonium sulfate, 0.1M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES)-sodium pH 7.5, 0.5M di-sodium hydrogen phosphate dihydrate, and 0.5M
di-potassium hydrogen phosphate plus 0.1M carbenicillin di-sodium.
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Crystals of OmpC28 and OmpC33 were obtained from conditions with 0.8~1% βOG both 
at 4°C and 20°C. Initial hits for OmpC28 and OmpC33 crystal were in a precipitant
containing 0.8% βOG, 0.1M HEPES pH 7.5, 0.1M MgCl2, 18% PEG400 at 20°C and 4°C,
respectively. These crystals diffracted to 4Å-5Å at our in house X-ray facility. To get
higher resolution, we started optimization of the conditions as well as other parameters like
temperature, concentration of the detergent and protein solutions, and additives. A further
48 optimized screening conditions were made as listed in Table 3.1.2.1.
Table 3.1.2.1 Optimization screen conditions for OmpC28
0.1M HEPES, pH 7.5
PEG400
(v/v, %)
(NH4)2SO4 (M)
0.05 0.075 0.1 0.15 0.175 0.2
15 1 1a 1b 1c 1d 1e
16.5 2 2a 2b 2c 2d 2e
18 3 3a 3b 3c 3d 3e
19.5 4 4a 4b 4c 4d 4e
21 5 5a 5b 5c 5d 5e
22.5 6 6a 6b 6c 6d 6e
24 7 7a 7b 7c 7d 7e
26 8 8a 8b 8c 8d 8e
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The best OmpC28 crystal was grown from optimized condition 5c with 0.1M HEPES, pH
7.5, 0.15M MgCl2, 21% PEG400 plus 50mM carbenicillin disodium at room temperature.
The protein was purified in 1% βOG. Although many OmpC crystals grew under the 
optimized conditions, they didn’t diffract to high resolution at our in-house X-ray facility.
The best OmpC33 crystal was from 0.1M HEPES, pH 7.5, 0.075M ammonium sulfate,
22.5% PEG400 at room temperature, with detergent 1% βOG. All the crystals were 
cryoprotected for data collection at 100 K by increasing the PEG400 concentration to 31%.
Because the crystals were extremely fragile, we used a step-wise soaking strategy for
cryoprotection. We replaced the well solution with higher PEG400 concentration with
several steps gradually up to the final cryoprotectant concentration. In some cases, the well
solution was replaced by PEG400 and left overnight or even days before directly freezing
the crystals.
3.1.3 Data collection and Structure determination
High resolution datasets for each protein crystal were collected on various beamlines at the
European Synchrotron Radiation Facility (ESRF, Grenoble, France). Data collection
parameters were shown in Table 3.1.3.1. Data were indexed and integrated using
MOSFLM (Leslie, 2006). For the OmpC26 diffraction data, because several crystals stuck
together resulting in multiple lattices (Figure 3.1.3.1), the strongest lattice at the high
resolution range 3Å-2.28Å was selected for indexing and the whole diffracting range (30
Å-2.28 Å) was used for cell refinement. Other datasets were indexed as normal.
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Table 3.1.3.1 Data collection for all the OmpC structures. Structures of OmpCO6 and
OmpC20 solved by Dr. Vicki Bamford were also included for completeness. However,
some information was not available to me as stated in this table.
Data collection
Dataset OmpCO6 OmpC20 OmpC26 OmpC28 OmpC33
ESRF beamline ID14.1 ID14.3 BM14 ID14.1 ID14.3
Wavelength (Å) 0.934 0.931 0.976 0.934 0.931
Crystal to ditector
distance (mm) not available not available 207.43 300.50 290.87
Oscillation range
(°) Not available Not available 0.5 0.5 0.25
Temperature of
data collection 100K 100K 100K 100K 100K
Exposure time per
image Not available Not available 30s 5s 30s
Single crystal or
Multiple crystals Single Single Single Single Single*
Space group P321 C2 P1 P63 P21212
Unit cell
dimensions
a, b, c (Å)
α, β, γ ( °) 
120.42, 120.42,
158.08
90, 90, 120
128.02, 74.20,
133.50
90, 124.75, 90
74.18, 93.68,
115.91
98.74, 108.79,
109.71
103.49, 103.49,
186.49
90, 90, 120
142.96, 164.64,
159.83
90, 90, 90
Resolution (Å) 2.5 2.7 30-2.3(2.42-2.30)**
51.78-2.85
(3.0-2.85)**
30-3.55
(3.74-3.55)**
Rmerge (%) 10.5 (51.6) 10.2(38.1) 8.4(45.2) 11.8(74.2) 9.8(32.7)
Completeness (%) 99.5(99.5) 99.9(99.6) 97.4(96.1) 96.5(97.4) 81.1(68.2)
I/σI 14.3(3.4) 13.1(3.0) 9.9(1.8) 15.5(2.8) 12.8(2.7)
Redundancy 4.7(4.7) 3.7(3.6) 2.2(2.1) 8.1(8.1) 5.2(3.6)
*: It was a single crystal, however, the dataset was collected at 5 parts by shooting at
different parts of the crystal.
**: Values shown in blackests were the outer shell resolution limits.
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Figure 3.1.3.1 Data processing of OmpC26 by Mosflm. The multiple lattices can be seen
after the main lattice (represented by yellow dots, bottom picture) was picked up.
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The CCP4 program POINTLESS (Evans, 2006) was used to assign the correct space
group. The POINTLESS results for OmpC26, OmpC28 and OmpC33 are showing below.
For OmpC26 data, POINTLESS output indicated the space group is P1:
Nelmt Lklhd Z-cc CC N Rmeas Symmetry & operator (in Lattice Cell)
1 0.943 9.40 0.94 90222 0.109 identity
Laue Group Lklhd NetZc Zc+ Zc- CC CC- Rmeas R- Delta ReindexOperator
P -1 *** 1.000 9.40 9.40 0.00 0.94 0.00 0.11 0.00 0.0 [-h,k,-h-l]
For OmpC28 data, POINTLESS strongly suggested the space group should be P63:
Nelmt Lklhd Z-cc CC N Rmeas Symmetry & operator (in Lattice Cell)
1 0.951 9.69 0.97 375648 0.095 identity
2 0.949 9.64 0.96 494054 0.109 *** 2-fold l ( 0 0 1) {-h,-k,+l}
3 0.054 1.42 0.14 475943 0.595 2-fold ( 1-1 0)
4 0.054 1.45 0.14 470903 0.580 2-fold ( 2-1 0) {+h,-h-k,-l}
5 0.055 1.47 0.15 493656 0.573 2-fold h ( 1 0 0) {+h+k,-k,-l}
6 0.054 1.45 0.14 470704 0.576 2-fold ( 1 1 0) {+k,+h,-l}
7 0.054 1.41 0.14 476945 0.593 2-fold k ( 0 1 0) {-h,+h+k,-l}
8 0.055 1.50 0.15 514887 0.598 2-fold (-1 2 0) {-h-k,+k,-l}
9 0.946 9.59 0.96 949231 0.121 *** 3-fold l ( 0 0 1) {-h-k,+h,+l} {+k,-h-k,+l}
10 0.946 9.58 0.96 957315 0.125 *** 6-fold l ( 0 0 1) {-k,+h+k,+l} {+h,+k,-h,+l}
Laue Group Lklhd NetZc Zc+ Zc- CC CC- Rmeas R- Delta ReindexOperator
> 1 P 6/m *** 0.993 8.17 9.62 1.45 0.96 0.15 0.11 0.59 0.0 [h,k,l]
2 P 1 2/m 1 0.003 6.14 9.66 3.52 0.97 0.35 0.10 0.45 0.0 [k,l,h]
- 3 P -3 0.003 6.12 9.64 3.52 0.96 0.35 0.11 0.45 0.0 [h,k,l]
4 P -1 0.000 5.49 9.69 4.20 0.97 0.42 0.09 0.41 0.0 [-h,-k,l]
5 C m m m 0.000 1.37 5.58 4.21 0.56 0.42 0.31 0.41 0.0 [-k,2h+k,l]
Zone Number PeakHeight SD Probability ReflectionCondition
1 screw axis 6(3) [c] 87 0.994 0.117 *** 0.917 00l: l=2n
1 screw axis 6(2) [c] 87 0.048 0.117 0.003 00l: l=3n
1 screw axis 6(1) [c] 87 0.039 0.117 0.003 00l: l=6n
For OmpC33 data, POINTLESS suggested the possible space groups can be P2221 or
P21212, or P212121. These space groups have been further tested when solving the structure
by molecular replacement.
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Nelmt Lklhd Z-cc CC N Rmeas Symmetry & operator (in Lattice Cell)
1 0.941 9.32 0.93 266896 2.046 identity
2 0.902 8.97 0.90 192635 2.482 *** 2-fold l ( 0 0 1) {-h,-k,+l}
3 0.900 8.96 0.90 284328 2.344 *** 2-fold h ( 1 0 0) {+h,-k,-l}
4 0.052 0.12 0.01 262715 3.494 2-fold ( 1 1 0) {+k,+h,-l}
5 0.949 9.52 0.95 190863 2.324 *** 2-fold k ( 0 1 0) {-h,+k,-l}
6 0.049 0.34 0.03 160798 3.313 2-fold ( 1-1 0) {-k,-h,-l}
7 0.051 0.18 0.02 386363 3.435 4-fold l ( 0 0 1) {-k,+h,+l} {+k,-h,+l}
Laue Group Lklhd NetZc Zc+ Zc- CC CC- Rmeas R- Delta ReindexOperator
> 1 P m m m *** 0.976 8.97 9.17 0.21 0.92 0.02 2.25 3.43 0.0 [-h,-l,-k]
2 P 1 2/m 1 0.012 5.64 9.39 3.74 0.94 0.37 2.13 2.96 0.0 [h,k,l]
3 P 1 2/m 1 0.006 5.49 9.17 3.68 0.92 0.37 2.18 2.94 0.0 [l,h,k]
4 P 1 2/m 1 0.006 5.79 9.15 3.36 0.92 0.34 2.17 3.03 0.0 [-h,-l,-k]
5 P -1 0.001 4.84 9.32 4.48 0.93 0.45 2.05 2.87 0.0 [-h,-l,-k]
6 P 4/m 0.000 1.34 6.09 4.75 0.61 0.47 2.52 2.80 1.7 [-l,-k,-h]
7 P 4/m m m 0.000 5.38 5.38 0.00 0.54 0.00 2.66 0.00 1.7 [-l,-k,-h]
8 C 1 2/m 1 0.000 -0.34 5.15 5.49 0.52 0.55 2.53 2.74 1.7 [k-l,-k-l,-h]
9 C 1 2/m 1 0.000 0.85 5.97 5.13 0.60 0.51 2.37 2.81 1.7 [-k-l,-k+l,-h]
10 C m m m 0.000 -0.75 5.05 5.80 0.51 0.58 2.64 2.69 1.7 [-k-l,-k+l,-h]
Zone Number PeakHeight SD Probability ReflectionCondition
1 screw axis 2(1) [a] No observations
2 screw axis 2(1) [b] 106 1.039 0.205 *** 0.940 0k0: k=2n
3 screw axis 2(1) [c] No observations
Choosing between possible best groups:
Space group Point group Reindex
P 2 2 21 P 2 2 2 [-k,-h,-l]
P 21 21 2 P 2 2 2 [-h,-l,-k]
P 21 21 2 P 2 2 2 [-l,-k,-h]
P 21 21 21 P 2 2 2 [-h,-l,-k]
SCALA was used for scaling and merging of the data. The resolution limit was determined
by the data statistics and the Wilson plot. The program XTRIAGE was applied to check the
data quality and reflection outliers were deleted for OmpC26 dataset. OmpC26, OmpC28
and OmpC33 datasets were also checked for the anisotropy by submitting to the
Diffraction Anisotropy Server (http://www.doe-mbi.ucla.edu/~sawaya/anisoscale/).
OmpC26 data shows slight anisotropy (data not shown) while OmpC33 data shows severe
anisotropy. Figure 3.1.3.2 shows the diffraction pattern of OmpC33 and its anisotropy
detected by the software. Ellipsoidal truncation and anisotropic scaling was performed for
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data of OmpC26 and OmpC33 datasets (Strong et al., 2006). Approximately 20% of
measurements were removed for OmpC26 data and 15% for OmpC33.
Figure 3.1.3.2 Diffraction pattern of OmpC33 (left) and its anisotropy detected by the
Diffraction Anisotropy Server (http://www.doe-mbi.ucla.edu/~sawaya/anisoscale/). The
red oval circle indicated the anisotropic diffraction pattern.
The structure of OmpC26 was solved by molecular replacement using the refined 2.7 Å
OmpC20 structure as the search model with the program MOLREP (Murshudov et al.,
1997) in the CCP4 program suite (CCP4, 1994). Caculation of the Matthews coefficient
suggested the presence of two trimers in the asymmetric unit with a coefficient value of
3.00 and water content of 59.0% based on a molecular weight of 38000 Da per monomer.
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Using a trimer search model and data in the resolution range 30 - 3 Å, clear solutions for
the two trimers in the asymmetric unit were obtained. The crystal packing was examined as
shown in Figure 3.1.3.3. The two trimers are associated loop-to-loop via hydrophilic
interactions. For further refinement, a 2 times 3-fold NCS restraints for each trimer and
TLS refinement for the two trimers were employed. In the last three rounds of refinement,
tight NCS restraints except for the residue 131, 284, and 322-326 was applied and 4 TLS
groups were assigned (1-50, 51-150, 151-275, 276-343, figure 3.1.3.4) according to the
TLSMD server (http://skuld.bmsc.washington.edu/~tlsmd/) (Painter and Merritt, 2006).
The 4 segments were generated by the program according to their structure flexibility
(Painter and Merritt, 2006).
Figure 3.1.3.3 Crystal packing of OmpC26 after molecular replacement.
Figure 3.1.3.4 TLS groups assigned by TLSMD server
(http://skuld.bmsc.washington.edu/~tlsmd/).
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The structure of OmpC28 was solved by MOLREP using the OmpC26 monomer as the
search model. Although there are two monomers in the asymmetric unit, symmetry
application resulted in a trimeric structure and the symmetry of space group resulted the
trimer structure (Figure 3.1.3.5).
Figure 3.1.3.5 Crystal packing of OmpC28 after molecular replacement.
Refinement proceeded in the same way as for OmpC26. The model was refined with 2-fold
NCS restraints and TLS. The map clearly shows the mutation site of S271F (Figure
3.1.3.6)
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Figure 3.1.3.6 Electron density map of the mutation site of S271F in OmpC28 at 1σ level 
and difference map at 3σ level. 
The structure of OmpC33 was solved by PHASER using the refined 2.3Å OmpC26
structure (trimer) as the search model. To verify the structure, we used the OmpC26
monomer as the search model and it gave the same molecular arrangement. Figure 3.1.3.7
shows the crystal packing of OmpC33. Because of the low resolution, no water molecules
can be assigned. By applying NCS and TLS following one round of manual building in
Coot, both Rfac and Rfree improved from 48.8% to 39.2% and 41.7%, respectively.
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Figure 3.1.3.7 Crystal packing of OmpC33 after molecular replacement.
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The stereochemical quality was analysed using MolProbity. Figure 3.1.3.8 shows the
Molprobity score for the OmpC26, OmpC28 and OmpC33 structure validation.
OmpC26:
OmpC28:
(figure continues)
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OmpC33:
Figure 3.1.3.8 Molprobity score for OmpC26, OmpC28 and OmpC33.
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3.2 Results and discussion
3.2.1 Overall structure of OmpC
Data statistics of all the OmpC structures were shown in Table 3.2.1.1. All mutant OmpC
crystal structures determined in this study share the same 16-stranded antiparallel -barrel
with a central pore first reported for OmpC from E. coli K12 (Basle et al., 2006). The
-strands are connected by 8 short turns (2 - 8 residues in length) on the periplasmic side
and 8 long loops (L1 to L8 of 9 - 30 residues in length) on the extracellular face. As
previously observed for the parent OmpC L3 is not exposed on the cell surface, but folds
back into the lumen of the barrel forming the constriction zone at middle of the channel.
The trimer interface is formed by the packing of hydrophobic residues on the outer edges
of strands 1 to 5 and further stabilised by L2 which reaches into the neighboring
monomer. In the trimer, the outside surface resembles a fully enclosed bowl with the walls
of the bowl formed by the loops 1, 4, 5, 6, 7 and 8 from each monomer. All of the amino
acid side chains in contact with the lipid bilayer on the outside of the OmpC trimer are
hydrophobic. This hydrophobic band is bordered by two rings of aromatic residues, 20 –
25 Å apart which lie at the interface between the lipid bilayer and the lipid head groups.
The outer facing ring consists predominantly of tyrosine residues with the hydroxyl group
pointing away from the bilayer towards the solvent. The inner facing ring consists of both
tyrosine and phenylalanine residues with the tyrosine hydroxyl groups again pointing
towards the solvent.
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Tabel 3.2.1.1 Refinement of OmpC structures. Structures of OmpCO6 and OmpC20 solved
by Dr. Vicki Bamford were also included for completeness.
dataset OmpCO6 OmpC20 OmpC26 OmpC28 OmpC33
Refinement
Resolution range
(Å) 50-2.5 50-2.7 30-2.3 50-2.85 30-3.55
No. of unique
reflections 43736 27027 118130 25455 37636
Refined structure 2 monomers (2 x
354 residues),
367 H2O, 2
ADA
1 trimer (3 x
343
residues),
340 H2O, 4
HESO
Two trimers (2
x 3 x
343residue
s), 389
H2O,
1HESO,
2OPOE,
34 acetyl
chain as
part of
detergents
, 6 SO4 2-,
1partial
HEPES
Two monomers,
2βOG, 32 
H2O
Two trimers
Rwork/Rfree (%) 18.6/22.0 23.1/28.5 24.0/27.5 22.1/24.6 39.2/41.7
R.M.S deviations
Bond length (Å) 0.016 0.005 0.008 0.005 0.011
Bond angles (°) 1.626 0.829 1.051 0.858 1.044
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The structure of OmpC from K12 and the OmpC clinical mutants are superimposable with
a root mean square deviation (r.m.s.d) of OmpC from K12 and OmpC26 of 0.34Å over 320
Cα atoms excluding the residues of L4. On the amino acid level there are many differences 
that a direct comparison was unhelpful to identify changes which might be responsible for
increased antibiotic resistance. We therefore decided to use the OmpCO6 structure as a
closer native, as sequence alignment suggests OmpC20-33 are derived from it. The crystal
structure of OmpCO6 was obtained at 2.5Å resolution. The OmpCO6 structure can be
superposed with OmpC26 with an r.m.s.d of 0.3Å over 320 Cα atoms excluding the 
residues of L4. In OmpCO6 the L4 overhangs the lumen of the bowl and protrudes to the
entrance of the trimer funnel (Figure 3.2.1.1). In the clinical OmpC mutants, the L4 is
shorter resulting in a reduced overhang (the interactions with L1 are conserved). As a
result of a number of sequence changes, the entrance to the pore of the clinical OmpCs has
a more negative electrostatic surface than OmpCO6 (Figure 3.2.1.1). The negative
electrostatic surface extends from the overhung loops to the bottom of the entrance funnel.
The amino acids lining the constriction zone are conserved between OmpCO6 and the
clinical OmpCs. The strong transverse electrical field at the constriction zone of the
channel is generated by a cluster of basic residues, K16, R37, R74 and R124 on the barrel
wall facing acidic residues, D105 and E109 on L3 for OmpCO6. This cationic cluster is
stabilised by hydrogen bonds between two residues on strand β4, Q59 and E57 and the NE 
atoms of R37 and R74 respectively. The residues that form this field are conserved in
OmpC20, 26, 28, and 33.
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Figure 3.2.1.1 Structure comparison OmpCO6 with OmpC20. (a) A superposition of the
OmpCO6 monomer shown in green with the OmpC20 monomer in orange. The main
difference is Loop4 as labeled. (b) The molecular surface of OmpC20 view from
extracellular side. (c) A superposition of OmpCO6 trimer in green and OmpC20 in orange.
The longer L4 in OmpCO6 contributes to narrowing the pore entrance. (d) Extracellular
surface of OmpCO6 (left) and OmpC20 (right). Acidic charged surface is coloured red and
basic charged surface is coloured blue. These figures were generated by PyMol.
L4
(a) (b) (c)
L4
L4 L4
(d)
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3.2.2 The mutation sites
The high resolution data of OmpC26 enabled us to probe the structure in detail especially
the constriction zone. Surprisingly, the basic residues at the constriction zone of OmpC26
monomer all have bound molecules larger than water. We modeled SO4 2- and a partial
HEPES molecule into the electron density of one particular monomer, respectively (Figure
3.2.2.1). The basic cluster residues K16, R37, R74 and R124 were involved in binding
while the acidic residues in L3 all have water bound. Investigation of the constriction zone
also reveals that there is room for only one HEPES-size molecule. It was initially
suggested that the constriction zone of OmpF monomer can accommodate one ampicillin
molecule regardless of the dissolvation (Nestorovich et al., 2002). Here, we provide the
first direct experimental evidence for substrate binding in the constriction zone of general
porins.
Figure 3.2.2.1 The constriction zone of OmpC26 channel. Left shows two SO4 2- bound to
R124, R74, R37 and K16. Right shows a partially modeled HEPES molecule binding to
the basic cluster. The red crosses represent water molecules bound to residues in L3.
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The clinical OmpC structures are identical except for the 3 mutations (D18E, S271F and
R124H) which are all located inside the pore (Figure 3.2.2.2A). In OmpC26 (which has the
D18E mutation) the longer side chain of glutamate protrudes into the lumen, thus slightly
narrowing the constriction zone. The carboxyl group of E18 is hydrogen bonded to K16, an
interaction not seen in OmpC20. Although the hydrogen bond of D18 with Y310 is
retained in E18, however a water molecule bound to the carboxyl group of E18 makes a
hydrogen bond network with E109 and Y310 (Figure 3.2.2.2B). In OmpC28 the S217F
mutation results in replacement of a water molecule that was bound to the hydroxyl of
S271 (Figure 3.2.2.2C). In the high resolution data of OmpC26, a water molecule bound to
S271 is at the center of a complicated hydrogen bond network between L3 and the barrel
wall. Q261, D296 and D312 were all hydrogen bonded to the residues at the tip of L3. The
bulky side chain of F271 not only disrupted the hydrogen bond network but also pushed
the tip of L3 slightly further (1 Å) into the constriction zone. In OmpC33, R124 is mutated
to a histidine residue. Due to the limited resolution of this structure, we cannot identify
side chain conformations, water structure or subtle perturbations in main chains of
OmpC33. However, the resolution is sufficient for us to be sure that the overall structure
has not changed and there is no large re-ordering of the constriction zone. In all other
OmpCs, R124 forms a strong salt bridge with E66 from L2 and hydrogen bonds to Y94
and S117 (Figure 3.2.2.2D). In OmpC33 the shorter side chain H124 will disrupt these
interactions. Since the experimental structure is unreliable for side chain position, we
modeled H124 as a common rotamer. Overall the mutations do not change the channel
shape or size appreciably.
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Investigation into the size and shape of the constriction zone revealed that although the
mutations do not change the channel shape, it is slightly narrower (Figure 3.2.2.3). Thus it
appears that the mutant proteins create or disrupt existing H bond networks within the
channel which might lead to the fundamental antibiotic resistance.
(A)
(B)
(figure continues)
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(C)
(D)
Figure 3.2.2.2. The 3 mutation sites (D18E, S271F and R124H) in the clinical OmpCs. (A)
the location of the mutation sites, view from the extracellular side (left) and from side of
membrane (right). L3 is colored purple. (B) mutation D18E. (C) mutation S271F. (D)
mutation R124H. The residue labeling here is according to the amino acids sequence of
OmpC20, not OmpCO6 as did in the sequence alignment in Figure 2.1.4.2.
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Figure 3.2.2.3 Constriction zone of variant OmpCs (A-E) and schematic representation of
the constriction zone (F). A is OmpCO6 shown as black in F, B is OmpC20 shown as
yellow in F, C is OmpC26 shown as green in F, D is OmpC28 shown as blue in F and
finally F is OmpC33 shown as red in F.
A
C
FE
D
B
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3.3 Discussion
Porins were among the first outer membrane protein structures being solved, due to their
redundant presence and their robust barrel nature. Porins are also believed to be important
in clinical antibiotic resistance (Pages et al., 2008) as numerous mutations are found.
However, no X-ray crystal structures have been reported on antibiotic resistant porins.
Here, for the first time we solved a series of OmpC porin structures.
Comparing the structure of the clinical OmpCs and the wild type OmpCO6 revealed the
size and shape of the channel is largely unchanged. The mutation of OmpC20 to OmpCO6
resulted in a more open access bowl and an increased electrostatic surface which might
facilitate the solute uptake.
It was proposed (Karshikoff et al., 1994; Liu and Delcour, 1998) that in OmpF the position
of L3 was controlled by a hydrogen bond network between the tip of L3 and the barrel
wall, salt bridges at the root of L3 and electrostatic interactions between the positive
cluster at the barrel wall and the negatively charged residues on L3. In S271F, the mutation
disrupts the hydrogen bond network and directly affects L3. The loss of the water molecule
in S271F will increased the hydrophobicity of the environment between the L3 and the
barrel wall. It has been reported that disrupting the hydrogen bond network between L3
and the barrel wall by site directed mutagenesis in OmpC (from E. coli K12) increases the
flexibility of L3 and closure events (Liu and Delcour, 1998). D18E makes a salt bridge
with K16 whilst R124H breaks a salt bridge with E66. It also reduces the net charge which
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sits across from the cluster of negative charges on L3. The structural work then supports a
model in which L3 is destabilized.
The passage of large charged molecules through OmpC requires that they are first
desolvated. Four basic residues cluster together (K16, R37, R74, R124) opposite the
negatively charged residues (D105 and E109) create a powerful transverse electric field
found in all porins (Simonet et al., 1996). It is this transverse electric field that governs the
desolvation energy and hence transport efficacy for large polar molecules (Saint et al.,
1996; Van Gelder et al., 1997). The use of charged residues to stabilize the desolvation
process is well known, for example in potassium ion channels (Doyle et al., 1998). The
mutations D18E and R124H directly change the transverse electric field altering the
position of charge and reducing the charge itself. We suggest that these modifications will
decrease the ability of the protein to stabilize desolvation, this will particularly affect large
highly charged polar molecules.
In summary, the structures suggest that the clinical isolates E. coli have evolved a subtle
strategy to perturb the stability and electrostatic field of OmpC. This strategy might allow
the bacteria to take up nutrients but to decrease their sensitivity to antibiotics (further
discussed in next chapter). Although studies of deliberately introduced antibiotic resistance
provide very clear results, clinical situations are always more complex but cannot be
ignored. In this case other changes in the E. coli strain are clearly involved in the
manifestation of clinical resistance. However, this study presents molecular evidence for
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and a rationale of how changes in OmpC contribute to clinically observed antibiotic
resistance. These findings should help us understand how antibiotic resistance develops.
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Chapter 4
Channel properties of the clinical OmpC
mutants
112
Summary
We wished to characterize the functional properties of the clinical OmpC mutants,
especially the first mutants OmpC20 (from antibiotic sensitive strain) and the last mutant
OmpC33 (from antibiotic resistant strain). Single channel measurements of ion
conductivity of the channels were carried out. We also tested the interaction of an
antibiotic with OmpC20 and OmpC33. With these data and the structural information
described in Chapter 3 we propose a novel strategy that bacteria developed during
antibiotherapy: it is the changes in the transverse electric field not pore size that underly
the clinically observed resistance to the antibiotics.
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4.1 Introduction
The planar lipid bilayer technique is often referred to “black lipid membranes” or “BLM’s”.
This technique is widely used in the electrophysiology lab nowadays to probe
channel-forming proteins to reveal their channel properties. As illustrate in figure 4.1.1,
two symmetrical chambers are separated by a Teflon film. In the middle of the Teflon film
there is a small hole with a diameter of ~100 μm. The chambers are normally filled with 
buffered KCl or NaCl solutions usually at 1M concentrations. Two Ag/AgCl electrodes are
immersed into the salt solutions and fixed voltages can be applied through these electrodes.
The electrodes are connected to signal amplifier which in turn connects to signal filter and
eventually connected to computer program which monitor the signals.
The core of the technique is to form an artificial planar lipid bilayer across the hole in the
film connecting two chambers (about 3 x 5 cm size). Lipids, usually 1,
2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC), dissolved in pentane were added to
each chamber that is filled with salt solutions. Because of the nature of the air-water
interface (hydrophobic/hydrophilic), lipids forms a monolayer at the air-water interface
after the pentane evaporated. By slowly lowering and raising the water level at the
chamber, the lipids move towards to the Teflon film and a bilayer can be eventually
formed at the hole (Montal and Mueller, 1972). Once the bilayer is formed, the optical
properties of the membrane will appear to be black, hence the name of the technique. In the
114
absence of added channel proteins, the conductance is very very low and well under
detection level.
(A)
(B)
Figure 4.1.1 The core of the planar lipid bilayer technique. (A) Chamber and the connected
electrodes, picture taken from Prof. Hagan Baylay’s lab at the University of Oxford. (B)
Schematic drawing of the chamber. Part a (left) shows the two symmetrical chambers
connected together, part b (right) shows an expanded view of an inserted porin within the
lipid bilayer. When applied with a certain voltage, cations and ions start follow at opposite
directions. (Picture adapted from Pages, 2008)
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One side of the chamber is connected to ground hence the potential is zero. Usually the
zero potential side is defined as cis side and the other as trans side. The purified protein is
often added to the cis side of the chamber, and spontaneous insertion can be seen over the
time. Most often, people apply a transmembrane voltage to facilitate the insertion. As
channels insert into the membrane, small ions find their way to cross the membrane and
therefore an increase in electrical current can be detected across the membrane. A typical
electrical current trace is shown in Figure 4.1.2a. The conductance values follow a
Gaussian distribution (Fig. 4.1.2b). The fit to this distribution yields an average
conductance which is used as the conductance value for a given channel.
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Figure 4.1.2 (a) Current trace of one trimeric OmpC20 channel reconstituted into planar
lipid bilayer under +50mV. Membrane bathing solutions contained 1M KCl (pH8). (b) The
histogram corresponding to the current trace above shows the value is around 97 pA.
A number of groups have investigated the flux of ions and small molecules through OmpF
and OmpC (Danelon et al., 2006; Delcour, 2003; Iyer and Delcour, 1997). Small ion
conductance measurements suggest that the pore size of OmpF and OmpC is
approximately 1nm (Danelon et al., 2006; Pages et al., 2008), with the trimeric
conductivity of OmpF measured in 1M KCl as 4.2nS (Basle et al., 2004; Danelon et al.,
2006). Site directed mutagenesis studies have indicated that there is no simple correlation
between the measured size of the pore at the constriction zone and the conductance of ions
(Bredin et al., 2002; Kleivdal et al., 1999; Phale et al., 2001).
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In recent years, the interaction of antibiotics with porin channels is increasingly
investigated by the technique of planar lipid bilayers (Danelon et al., 2006; James et al.,
2009; Nestorovich et al., 2002). Using the inserted porin channel as a control, addition of
antibiotics resulted in ion current fluctuation and analysis of the noise provide information
on the channel properties (Nestorovich et al., 2002). Figure 4.1.3 gives a nice example of
ampicillin interacting with an OmpF channel that is inserted into the lipid bilayer (figure
from Nestorovich et al., 2002).
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Figure 4.1.3 Ampicillin interact with a single OmpF channel that is inserted into the planar
lipid bilayer. (Top) Control experiment without addition of ampicillin, the current is
peaceful. (Middle) By addition of 6mM ampicillin, the current become extremely noisy
and one of the monomers gets blocked. (Bottom) Increasing the concentration of ampicillin
results in an increase of noise and two of the monomers get blocked. (Figure adapted from
Nestorovich et al., 2002).
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4.2 Materials and methods
4.2.1 Single channel conductance experiments
Single-channel recordings on planar lipid bilayers were carried out as described previously
(Movileanu et al., 2000). Briefly, a 25-μm-thick Teflon film (Goodfellow) with a 100 μm 
diameter hole partitioned two 1.5-ml chambers. The orifice was pretreated with ~5μl 10% 
(v/v) hexadecane dissolved in high-purity pentane. Each chamber was filled with 1 ml 10
mM Tris-HCl, pH 8.0, 1M KCl. A solution of 10 μl 10% (v/v) 1, 
2-diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) dissolved in pentane
was added to each bath and monolayer formed after the pentane evaporated. By lowering
and raising the solution, two lipid monolayers formed a lipid bilayer at the orifice, which
was confirmed by its resistance and capacitance. The transmembrane potential was applied
through the two Ag/AgCl electrodes immersed in each bath. The cis chamber was
connected to ground so the potential will always be zero. A positive current is one in which
cations flow from the trans to the cis side and anions flow from the opposite way.
Experiments were conducted at room temperature around 20°C.
Single-channel current was amplified with an Axopatch 200B patch-clamp amplifier
(Axon Instruments), and filtered at 2 kHz with a built-in low-pass Bessel filter. Signals
were digitized with a Digidata 1200 A/D converter at a sampling rate of 20 kHz and
recorded by Clampex 9.2 software (Axon). The data were analyzed with the software
pClamp 6.03 (Axon) and Origin (Microcal Software Inc.). OmpC purified in 1% βOG at a 
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final concentration of 0.5-1 μg/ml or the OmpC protein crystals were added to the cis
compartment. Trimeric channels were inserted into the bilayer by applying electrical
potentials of 250-300 mV and were stabilized for recording by lowering the voltages below
250mV.
Studies of the interaction of a range of antibiotics with OmpC were performed at Tris-HCl
buffer, pH 8.0, 0.5M KCl instead of 1M KCl as in the single channel conductance
measurement, because we observed that the OmpC channels were less noisy at lower salt
concentration in the single-channel current recording. Antibiotic stock solution was added
to the cis/trans chamber to the desired final concentration after a single channel insertion.
Signals were filtered by the built-in low-pass Bessel filter at 10kHz and data saved at a
sampling rate of 100kHz.
4.2.2 Thermal stability test
SDS-PAGE was performed to determine the thermal stability of the OmpC mutants.
Protein purified in 1% βOG was added to NuPAGE sample buffer (Invitrogen), and 
incubated for 10min at various temperatures (35 ºC- 100 ºC, in steps of 5 ºC). After the
heat treatment, protein samples were immediately transferred to ice before loading onto the
NuPAGE 4-12% Bis-Tris gels (Invitrogen). Gels were run at 200 V for 35mins in MES
running buffer, pH 7.4, following the manufacturer’s protocols. Proteins were stained by
Coomassie blue staining. MW values were estimated from the migration rates of Mark-12
markers (Invitrogen).
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4.3 Results and discussion
4.3.1 Single channel measurements
The effect of mutation on the ion conductance was probed by single channel current
recording. Initial investigation was done based on 20-30 independent experiments for each
OmpC mutant. We observed that all the OmpC mutants have a broad range of conductance
value ranging from ~0.6nS to ~3.0nS (Figure 4.3.3.1). The conductance at positive and
negative potential is slightly different depending on the voltage polarity. This is a
consequence of the direction of ion flow in an inherently asymmetric structure.
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(figure continues)
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Figure 4.3.1.1 Distributions of the conductance calculated from the current recording under
+ and -50mV. The bathing solutions contained 1M KCl (pH8) on both side of membrane.
The respective mutants with the positive/negative voltage applied are indicated above each
OmpC26 +50mV
OmpC28 +50mV
OmpC33 +
OmpC26 –50mV
OmpC28 -50mV
OmpC33 -
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chart. The conductance is in nS, the percentage of events in one of the bins is given as P
(%). Only the data with steady traces acquired for at least 30 seconds were analysed and
counted.
In order to ensure these varied conductance states are derived from a single trimeric OmpC
channel rather than contamination, we repeated the experiments using proteins dissolved
from the crystals. The results were the same. In order to get a statistically valid result, we
performed more than 70 independent experiments for OmpC20 and OmpC33 respectively.
Figure 4.3.1.2 shows the distribution of single trimeric conductance in 1M KCl of
OmpC20 and OmpC33 measured under the voltage of ±50mV. On average, OmpC20 has a
conductance of 2.1nS (±0.68nS) while OmpC33 has 1.9nS (±0.65nS); the largest
conductance for OmpC20 was 3.3nS while for OmpC33 was 3.0nS. These values are
bigger than what has been reported for OmpC trimeric conductance (Bishop et al., 1996;
Mobasheri and Lea, 2002), under different experimental conditions. However, it is in good
agreement with OmpF measured in similar conditions (Nestorovich et al., 2002; Schmitt et
al., 2006). The mutations appear to have almost no effect on small ion transport.
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Figure 4.3.1.2 Distribution of ion conductance calculated from the current recording under
+-50mV (B). The buffer used is 1M KCl (pH 8) on both side of chamber. Only the data
with steady traces acquired for at least 30 seconds were analysed and counted. Each plot
was based on 100-130 experiments. The downward arrow represents the average
conductance value with OmpC20 of 2.0nS while OmpC33 of 1.9nS.
The variation in conductivity was unexpected and was investigated further to exclude
artifacts. The highest conducting state of OmpC (3.3 nS) reproducibly undergoes three step
closure at voltages >200mV as shown in figure 4.3.1.3. We interpret this as sequential
closure of the monomers within the trimer and that the maximum value as all three
monomer channels in the trimer being open. In order to evaluate genuine variation in
conductivity, single channel conductance was measured at 50mV, the voltage was then
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increased to 250mV for around 30s then the voltage decreased to 50mV (Figure 4.3.1.3).
After this process when the voltage is set to 50 mV, the current does not always return to
the same value even for the same protein. We suggest this demonstrates that there is
genuine variety of conducting states even for a single trimeric OmpC channel.
Figure 4.3.1.3 Experiment of single channel conductance measurement with varied
voltages. At time before 170s, the voltage was set to -50mV, following by +50mV, then
the voltage was jumped to +250mV where sequential steps closure took place. When the
voltage was set back to +50mV, the current was no longer as the same as at previous
+50mV (100pA), as well as did at -50mV.
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Porins are also known to oscillate spontaneously between open and closed states at low
voltages (Delcour, 2002). In a detailed examination of the fully open traces of OmpC20
and OmpC33, we observed a slightly different pattern of short-lived events at -50mV
(Figure 4.3.1.4). In OmpC33 there is an additional closure event corresponding to around
28% of conductivity (both OmpC33 and OmpC20 show a 9% closure event). This short
lived event is not seen for OmpC20 suggesting that the OmpC33 trimer is more
conformational flexible than OmpC20.
Figure 4.3.1.4 Traces of open channels of OmpC20 (bottom) and OmpC33 (above) under
-50 mV shows different short-lived transition events. In OmpC20, the closing current is
about 9% (Δ14.7pA) of original; in OmpC33, the closing current is either 9% (Δ12.1pA) or 
29% (Δ38.5pA). 
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4.3.2 Antibiotic (gentamicin) interaction with OmpC20 and OmpC33
Once the picture of trimeric conductance is clear, we wished to investigate the interaction
of antibiotics with OmpC20 and OmpC33. Molecular dynamics study suggested there is
only one ampicillin molecule moving through the monomeric channel of OmpF
(Nestorovich et al., 2002); our structure OmpC26 with partial HEPES molecule bound
supported this suggestion (see Chapter 3). Therefore, before carrying out the experiment, it
is known that only one antibiotic molecule can pass through the OmpC monomeric
channel.
We used the single channel conductance measurement as the control. A series of
antibiotics were tested to see the interaction (data not shown) and only gentamicin gave
clear signals. We preceeded with the experiment with gentamicin. It is worth mentioning
that gentamicin itself does not penetrate nor break down the bilayer. Experiments with
gentamicin at a concentration of 300μM added to the cis chamber solution (no porin
addition) showed no interaction with a stable bilayer within 10 minutes of stirring, the
traces after adding gentamicin therefore reveal the interaction of gentamicin and OmpC
channel.
When a porin was inserted into the bilayer, gentamicin induces closure of a single open
OmpC20 pore (Figure 4.3.2.1). It triggers several types of closing events. In a completely
open pore, the most time-enduring events are about 25% closure of original current.
Double blockages decreasing the current by nearly two thirds can be also seen (Figure
128
4.3.2.1). We interpret this type of event as gentamicin passing through the monomers as
seen on the report with ampicillin interact with OmpF (Nestorovich et al., 2002).
Figure 4.3.2.1 Gentamicin interacting with an open pore of OmpC20. Measurement was
under +50mV. Time scale is 3s for both (a) and (b). (c) is 3000X zoom in of the red part of
(b). (a) without gentamicin, the current trace was stable; (b) With gentamicin addition,
there’s increased noise (spikes) among which the majority is about 1/3 current reduction
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(a) Control: without gentamicin
(b) 300μM gentamicin
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that corresponding to one monomer blockage. There’s also 2/3 current reduction which
indicates two monomers blockage.
Investigation on the interaction of OmpC33 with gentamicin is largely hindered because of
the noisy traces of OmpC33 itself. Most ofen, the channel disappeared from the bilayer
after a short while, therefore recording the data became extremely difficult. Comparing to
the traces of OmpC20 interacting with gentamicin, OmpC33 rarely has double blockages
(Figure 4.3.2.2). This suggests that it is harder for gentamicin to get through OmpC33 than
OmpC20.
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Figure 4.3.2.2 Gentamicin interacts with an OmpC33 open pore. Measurement was under
+50mV at room temperature. (a) In the control experiment (without gentamicin added), the
pore itself has short-time closure corresponding to nearly one third of the whole channel
conductance. (b) Gentamicin induces channel closure in many forms, however, no double
blockage was observed as with OmpC20. (c) zoom in the red part of (b).
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4.3.3 Thermal stability
From the single channel experiment, particularly the experiment of gentamicin interaction
with OmpC channel, we observed that OmpC33 might not be as stable structurally as
OmpC20. To test this hypothesis, we tested the thermal stability of trimers. Using
SDS-PAGE (see methods) we observed that OmpC33 runs as a monomer (rather than
trimer) at above 60 ºC whereas the equivalent transition for OmpC20 is around 70 ºC
(figure 4.3.3.1).
Figure 4.3.3.1. Comparison of thermal stability between OmpC20 and OmpC33. The
temperatures (ºC) are indicated at the top.
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4.4. Discussion and Conclusion
In this chapter, single ion conductance measurement was carried out to characterize the
channel properties of the OmpC mutants; gentamicin interaction with OmpC20 and
OmpC33 was also investigated. The small ion flow through OmpC20 and OmpC33 are
very similar suggesting that the pore size is unaffected by mutation. This would seem to
disfavour a mechanism of simply narrowing to explain antibiotic resistance. The
conductivity experiments show the existence of conducting sub-states in OmpC20 and
OmpC33. Evidence for such states had been reported in OmpF (Basle et al., 2004; Buehler
et al., 1991).The molecular mechanism by which porins open and close is not clear. Some
outer membrane protein crystal structures show the inward directed loop to have different
conformations under different pH (Yildiz et al., 2006) or upon ligand binding (Ferguson et
al., 2002b; Ferguson et al., 1998; Locher et al., 1998; Yue et al., 2003) suggesting that the
inward directed loop is flexible. Many have suggested that conformational changes in this
loop underpin the changes in channel conductance. OmpC33 compared to OmpC20
exhibits a short lived but significant (approx 30%) closure event. Our interpretation of this
result is that L3 in OmpC33 is more conformationally dynamic than in OmpC20. Recent
modelling studies have proposed that the involvement of L3 in voltage-dependent closure
of porins (Delcour, 2008). The redistribution of ions within the pore change the
electrostatics that bind the L3 loop to the barrel wall (Delcour, 1997) might lead to changes
in L3 structure and closure of the channel.
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Experiments of gentamicin interaction with OmpC20 and OmpC33 show that this
antibiotic triggers closures of OmpC channels. Although gentamicin does not depend on
the OmpC pathway to go through the outer membrane, the molecular size (~477Da) is well
within porin’s limitation to take up hydrophilic nutrients (~600Da). Gentamicin may serve
as a model molecule to study the interaction of other antibiotic with OmpC. It is intriguing
that with OmpC20 gentamicin seems to go through the channel as similar interaction
pattern was found in ampicillin interacting with OmpF (Nestorovich et al., 2002). However,
OmpC33, with only 3 amino acids change from OmpC20, undergoes a different interation
pattern as no double closure was observed which indicates the difficulty for gentamicin go
through this porin. The flexibility of OmpC33 structure might play an important role to
protect the cell when encountering deadly foreign compounds.
That OmpC33 might be less conformational stable was also seen in a crude test of protein
stability. The OmpC33 trimer breaks down into monomers in SDS gel loading buffer at
10ºC lower than OmpC20. Although the 60ºC temperature at which this happens, and the
presence of SDS are not biologically relevant, it does point to a quite significant
perturbation in stability.
In summary, with the data of structural information, the results showed molecular evidence
for a rationale of how changes in OmpC contribute to clinically observed antibiotic
resistance. Bacteria may have clever strategy to cope with harsh environment by
developing subtle changes within some important proteins. The study here presents the
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channels are functional but block the drugs. These findings should help us understand how
antibiotic resistance develops.
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Chapter 5
Crystallization of a new outer membrane
protein Wzi from E. coli
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Summary
This project dealt with a new outer membrane protein that is involved in the biosynthesis
and translocation mechanism of K30 antigen from E. coli. The mechanism is a complicated
process that requires several proteins including outer and inner membrane proteins. In
order to gain insight into the mechanism it is essential to solve the structures of the proteins
and understand how they interact with each other. In this study, Wzi, a new outer
membrane protein was investigated. The protein was successfully expressed, purified and
crystallized. Initial crystals were tested and diffracted to 15 Å. A robust optimization
process was established and better quality crystals were obtained. A crystal which
diffracted to 2.4Å has been obtained.
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5.1 Introduction
5.1.1 E. coli Capsules
E. coli residing in the human gastrointestinal tract in general are not harmful, however,
they sometimes can be toxic causing a number of diseases including gastro-intestinal and
urinary tract infections, meningitis, and septicemia (Corbett and Roberts, 2008). The
reason for this transition is that toxic E. coli are capable of expression of a polysaccharide
capsule or K antigen which is a strong virulence factor. The capsule is a layer of
high-molecular-weight acidic polysaccharides that are tightly attached to the cell surface
(Whitfield, 2006). There are about 80 different K antigens in E. coli with varying sugar
compositions and polysaccharide linkages. Recently the capsules are divided into four
groups based on their genetics and biosynthesis (Whitfield and Roberts, 1999). Only group
1 and 4 are synthesized and assembled via the Wzy-dependent pathway (Whitfield, 2006).
Our laboratory is particularly interested in the biosynthesis of group 1 capsules and we are
focusing on the E. coli K30 serotype which is the prototype.
5.1.2 Wzy-dependent pathway
In the Wzy-dependent pathway (Figure 5.1.2.1), undecaprenol pyrophosphate
(und-PP)-linked repeat units are compiled by glycosyltransferases at the cytoplasmic face
inside the inner membrane (Drummelsmith and Whitfield, 1999). The inner membrane
protein Wzx, a putative flippase, facilitates the transport of the repeat units across the inner
membrane (Whitfield, 2006). These repeat units are then polymerized by Wzy at the
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periplasmic face. Wzy is an enzyme that transfers the polymer chain to the incoming
und-PP-linked repeat unit. The next step involves Wzc, an inner membrane protein with
tyrosinase autokinase activity. Wzc is only active when its C-terminal tyrosine residue is
phosphorylated (Whitfield, 2006). The level of phosphorylation of Wzc has some impact
on the capsular polysaccharides production (Paiment et al., 2002). Subsequently, Wzb, a
phosphatase enzyme that dephosphorylates Wzc, also takes part in the polymer expression.
After polymerization, Wza, the α-helical octameric outer membrane lipoprotein acts as an 
export channel for the glycopolymer (Dong et al., 2006). Wzi is the last protein in the
Wzy-dependent pathway and has been shown to play a late role in the capsular assembly
pathway (Rahn et al., 2003).
Figure 5.1.2.1 The Wzy-dependent pathway of group 1 and 4 capsular polysaccharides
biosynthesis and assembly in E. coli.
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5.1.3 Wzi and aim of this project
Our laboratory has been engaging the capsular synthesis and assembly pathway by solving
the structures of important proteins. Structures of Wza (Dong et al., 2006) and, more
recently Wzb (Hagelueken et al., 2009) have been solved and published. As an ongoing
effort, it is important to solve the structure of each protein that is involved in this pathway.
Wzi is predicted to be an outer membrane β-barrel protein (Rahn et al., 2003). With the 
experience of successfully purifying and crystallizing the OmpC outer membrane protein,
it is easier to apply these techniques to another β-barrel protein. 
Apart from Wza, Wzi is the second outer membrane protein involved in the capsule
synthesis and assembly pathway (Rahn et al., 2003). Studies of Wzi mutant strain showed
a significant reduction of capsule production on the cell surface (Rahn et al., 2003)
suggesting that Wzi is important. Although it is believed that Wzi might serve as a late role
in the capsular assembly pathway (Rahn et al., 2003), the exact function is not yet known.
This might largely depend on the structure that awaits to be solved.
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5.2 Material and Methods
5.2.1 Expression, extraction and purification of Wzi
The DH5α E. coli cells containing the plasmid vector pWQ193 which is a pBAD24
derivative was provided by our collaborator Prof. C. Whitfield at Guelph University,
Canada (Rahn et al., 2003). The pWQ193 vector contained the required gene coding for
ampicillin resistance and overexpression of the target protein from the E. coli B44
(O9:K30) strain. E. coli DH5α cells containing the antibiotic ampicillin (100 µl/ml, Roche 
Diagnostics GmbH) were grown in LB medium at 37°C. Cells were grown to an OD600 of
0.8 and were induced with 0.02% L-arabinose. After induction with L-arabinose, cells
were grown for a further 5 hours to achieve a maximum protein production. The cells were
collected by centrifugation at 6,000g (Beckman-Coulter™ with JLA 8.1000 rotor) and
used directly for next steps of purification or stored as a paste at -80°C.
Cells harvested from the fermentation were typically resuspended in 200mL (this volume
varied, usually the ratio of buffer to paste was 5:1) 20mM sodium phosphate buffer (pH
7.4) plus 50mM sodium chloride. Bacterial cells were mixed to a homogenous state
before passing through cell disruptor. Cells were disrupted twice at 30Kpsi and the crude
extract was fractionated by ultracentrifugation (100,000g) for 1 hour at 4°C
(Beckman-Coulter Optima™ L-90K Ultracentrifuge with 70Ti rotor). The supernatant
solution was discarded and the pellet containing cell membranes was re-suspended in
200mL 20mM sodium phosphate, pH7.4, 50mM sodium chloride with 2% N-lauryl
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sarcosine (Sigma Aldrich) to solubilise the inner membranes (Filip et al., 1973). The crude
extracts were incubated at room temperature with rolling for 4 hours. The extract went
through ultracentrifugation again at 100,000g for 1 hour at 4°C. The supernatant solution
was then discarded and the pellet containing the outer membranes was re-suspended in
200mL 20mM sodium phosphate, pH7.4, 50mM sodium chloride with 0.5% SB3.14
(Sigma Aldrich). The membranes were incubated with rolling overnight at room
temperature. The insoluble materials were then removed by centrifugation at 100,000g for
1 hour at 4°C.
As for the OmpC (Chapter 3), a similar two-step purification strategy was applied to purify
Wzi. Affinity and size exclusion chromatography were used. All purifications were carried
out with an AKTA purifier. The first step is the affinity chromatography using a 5ml
chelating nickel column (HisTrap™ FF, GE Healthcare) which was equilibrated with
20mM sodium phosphate, 500mM sodium chloride and 0.05% SB3.14 (Sigma Aldrich).
Wzi is C-terminal hexa-histidine tagged, this ensures its effectiveness of binding to the
Nickel column. Once bound, the detergent in the running buffer is changed to 0.1%
LDAO (Anatrace, 99.96% purity). The protein is step-washed by a series of imidazole
concentrations: 0mM, 12.5mM, 25mM, 50mM, 100mM, and 500mM (Figure 5.2.1.1).
Protein eluted corresponding to every peak was checked by SDS-PAGE (Figure 5.2.1.1)
and the target protein Wzi was pooled.
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Further experiments used the detergents β-OG (1%) (Melford Laboratories Ltd.) OPOE 
(0.5%) (Bachem, UK Ltd.) and C8E4 (0.45%) (Anatrace, 99.93% purity) instead of LDAO.
Figure 5.2.1.1 Nickel affinity chromatography for Wzi purification and protein purity
checked by SDS-PAGE.
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A further step of purification, gel filtration, was applied to remove the aggregates, lipids
and imidazole (Figure 5.2.1.2). The running buffer was 20mM Tris-HCl with the detergent
used in the last step of Nickel affinity chromatography. Protein purity was checked again
by SDS-PAGE (Figure 5.2.1.2) and protein identity was checked by Mass-spec (Figure
5.2.1.3). Trypsin digestion finger-printing shows the matching sequence of Wzi is 61% as
shown red below:
1 AQAYAAGLVV NDNDLRNDLA WLSDRGVIHL SLSTWPLSQE EIARALKKAK
51 PSYSSEQVVL ARINQRLSAL KADFRVTGYT STDQPGTPQG FGQTQPADNS
101 LGLAFNNSGE WWDVHLQGNV EGGERISNGS RFNANGAYGA VKFWNQWLSF
151 GQVPQWWGPG YEGSLIRGDA MRPMTGFLMQ RAEQAAPETW WLRWVGPWQY
201 QISASQMNQY NAVPHAKIIG GRFTFSPIQS LELGASRIMQ WGGKGRPESL
251 SNFWDGLTGK DNTAANDPNE PGNQLAGFDF KFKLEPTLGW PVSFYGQMIG
301 EDESGFLPSA NMFLGGIEGH HGWGKDAVNW YLEAHDTRTN MSRTNYSYTH
351 HIYKDGYYQQ GYPLGDAMGG DGQLVAGKVE LITEDNQRWS TRLVYAKVNP
401 ENQSINKAFP HADTLKGIQL GWSGDVYQSV RLNTSLWYTN ANNSDSDDVG
451 ASAGIEIPFS L
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Figure 5.2.1.2 Gel filtration and SDS-PAGE. Protein sample was quite pure after this step
as indicated by the gel.
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Figure 5.2.1.3 Matching mass for Wzi after trypsin digestion. The red spikes are the
peptides that matching the amino sequence of Wzi. The blue spikes are noise.
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5.2.2 Initial crystallization of Wzi
Prior to any crystallization experiments, the protein solution was treated by
ultracentrifugation (100,000g, 1hour, 277K) to remove aggregates. Crystallization trials
were performed using the screen MemplusTM (Molecular Dimensions Limited),
MembFac™ (Hampton Research) or the Sigma™ screen (BioChemika). The protein
concentration used for crystallization was 8-19 mg/ml. The sitting drop vapor diffusion
technique was applied throughout the screening and optimization process, with protein
drops of 2 µl and a 1:1 ratio of protein: precipitant set up against 100 µl of reservoir
solution. The crystallization trials were set up both at cold room temperature (4°C) and
room temperature (20°C). A summary of the crystallization trials is listed in Table 5.2.2.1.
Crystals with different shapes appeared after a couple of days up to weeks even months in
different conditions (Figure 5.2.2.1).
Table 5.2.2.1 Crystallization conditions for Wzi (C-his6) protein.
Detergent Screen
Protein
Concentration
(mg ml-1)
Method Temperature
0.1% LDAO Memplus 11.4 SD1 20°C
0.1% LDAO Memplus 19.1 SD 20°C
0.1% LDAO Memplus 12.5 SD 4°C
0.1% LDAO Membfac 10.8 SD 4°C
0.1% LDAO Sigma 10.8 SD 4°C
1% β-OG Memplus 12.8 HD2 20°C
1% β-OG Memplus 12.8 HD 20°C 
1% β-OG Memplus 8 SD 4°C 
1% β-OG Membfac 8 SD 4°C 
1% β-OG Sigma 8 SD 4°C 
0.45% C8E4 Memplus 11.39 SD 4°C
0.45% C8E4 Membfac 11.39 SD 4°C
0.45% C8E4 Sigma 11.39 SD 4°C
SD1: Sitting drop; HD2: Hanging drop.
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Figure 5.2.2.1 Different crystal forms of Wzi purified in 0.1% LDAO obtained in two
different conditions. Left: crystal observed in one week in MemPlus™ condition #15 at
4°C: 0.1M sodium chloride, 0.1M EPPS (pH 8.0) and PEG 1500 (33% w/v). Right:
crystals grew after two months in the condition of MemPlus™ condition #17 at 4°C: 0.1M
sodium cacodylate (pH 6.5), PEG 2000 MME (12.5% w/v).
5.2.3 X-ray characterisation and optimization of wzi crystals
Crystals were frozen by placing them into liquid nitrogen prior to screening at our in-house
X-ray facility. Crystals were cryo-protected using a step-wise soaking strategy. Briefly, the
soaking solution with high concentration of glycerol (~20%) or PEG400 (30%) as final
cryoprotectant is defined 100%, soaking solutions without any cryoprotectant is defined
0%. The step-wise soaking usually go through from 0%, 10%, 50% and 100%. Initial
crystals diffracted to 20 Å (data not shown) from the condition: 0.1M sodium chloride,
0.1M EPPS (pH 8.0) and PEG 1500 (33% w/v). After two months a crystal diffracted to
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~10Å at Diamond beamline (Figure 5.2.3.1) from a new condition: 0.1M sodium
cacodylate (pH 6.5), PEG 2000 MME (12.5% w/v).
Figure 5.2.3.1 Crystals that diffracted to ~10 Å at Diamond beamline. The condition was at
cold room temperature (4°C), protein purified in 0.1% LDAO with concentration of
12.5mg/ml, Memplus screen condition No.17: 0.1M sodium cacodylate pH 6.5, 12.5%
(w/v) PEG 2000 MME, with protein solution 2μl plus 2μl mother liquor, after 2 months of 
incubation, diffraction to ~10 Å shown in the picture right.
Optimised crystallisation trials were set up using the conditions in Table 5.2.3.1 as a base,
a number of salts were added as well as glycerol and the additive 1,2,3-heptanetriol.
Summary from recent publications on outer membrane proteins crystallization suggest
1,2,3-heptanetriol is the most successful additive so far (Newstead et al., 2008). Table
5.2.3.2 summaries the salts and additives used for optimisation.
8 Å
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Table 5.2.3.1 Optimisation conditions originated from the initial growth condition: 0.1M
sodium cacodylate (pH6.5), PEG2000 MME 12.5% as highlighted in the table.
Tube # Buffer pH Percipitant
1 0.1M sodium cacodylate 6.25 PEG2000 MME 8%
2 0.1M sodium cacodylate 6.25 PEG2000 MME 10%
3 0.1M sodium cacodylate 6.25 PEG2000 MME 12.5%
4 0.1M sodium cacodylate 6.25 PEG2000 MME 14%
5 0.1M sodium cacodylate 6.25 PEG2000 MME 16%
6 0.1M sodium cacodylate 6.25 PEG2000 MME 18%
7 0.1M sodium cacodylate 6.5 PEG2000 MME 8%
8 0.1M sodium cacodylate 6.5 PEG2000 MME 10%
9 0.1M sodium cacodylate 6.5 PEG2000 MME 12.5%
10 0.1M sodium cacodylate 6.5 PEG2000 MME 14%
11 0.1M sodium cacodylate 6.5 PEG2000 MME 16%
12 0.1M sodium cacodylate 6.5 PEG2000 MME 18%
13 0.1M sodium cacodylate 6.75 PEG2000 MME 8%
14 0.1M sodium cacodylate 6.75 PEG2000 MME 10%
15 0.1M sodium cacodylate 6.75 PEG2000 MME 12.5%
16 0.1M sodium cacodylate 6.75 PEG2000 MME 14%
17 0.1M sodium cacodylate 6.75 PEG2000 MME 16%
18 0.1M sodium cacodylate 6.75 PEG2000 MME 18%
19 0.1M sodium cacodylate 7 PEG2000 MME 8%
20 0.1M sodium cacodylate 7 PEG2000 MME 10%
21 0.1M sodium cacodylate 7 PEG2000 MME 12.5%
22 0.1M sodium cacodylate 7 PEG2000 MME 14%
23 0.1M sodium cacodylate 7 PEG2000 MME 16%
24 0.1M sodium cacodylate 7 PEG2000 MME 18%
Table 5.2.3.2 Salts and additives used for Wzi crystallization optimisation.
Additive Name Concentration
NaCl 0.1M; 0.2M; 0.3M
CaCl2 0.1M
MgCl2 0.1M
Li2SO4 0.1M
Glycerol 10%, 20%
1,2,3-heptanetriol 1.5%
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Within two weeks, in contrast to two months initially, crystals started to form in several
conditions and the size was generally bigger than previously obtained (Figure 5.2.3.2)
Figure 5.2.3.2 Crystal forms before (left) and after (right) optimisation. Microscope
zooming scale was the same level.
The diffraction resolution was also improved, with one crystal diffracted to 4Å using our
in-house X-ray facility (Figure 5.2.3.3). However, the diffraction pattern was anisotropic
that a dataset was not collectable.
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Figure 5.2.3.3 Crystals diffracted to ~4 Å at in-house X-ray facility. The growth condition
was at cold room temperature (4°C), protein purified in 0.1% LDAO with concentration of
12.5mg/ml in 0.1M sodium cacodylate pH 6.5, 12.5% (w/v) PEG 2000 MME, with protein
solution 2μl plus 2μl mother liquor, after two weeks of incubation. 
We also tested the crystals grown in the other optimized conditions, Table 5.2.3.3
summaries the crystals that had been tested. All of these crystals diffracted to 5-7Å at the
highest resolution range, however, no dataset was collected as the diffraction pattern was
quite anisotropic.
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Table 5.2.3.3 Summary of crystals analysed by in-house X-ray facility.
Buffer pH Precipitant Salt Detergent
Protein
Conc.
(mg/ml)
0.1M sodium
cacodylate 6.25 8% PEG 2000 MME
0.1M
Li2SO4
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
10% PEG 2000
MME
0.1M
Li2SO4
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
12.5% PEG 2000
MME
0.1M
Li2SO4
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.5
14% PEG 2000
MME 0.M Li2SO4
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25 8% PEG 2000 MME -
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
10% PEG 2000
MME -
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
10% PEG 2000
MME 0.1M NaCl
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
14% PEG 2000
MME 0.1M NaCl
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
16% PEG 2000
MME 0.1M NaCl
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.5
14% PEG 2000
MME 0.1M NaCl
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.5
18% PEG 2000
MME 0.1M NaCl
0.1%
LDAO 12.5
0.1M sodium
cacodylate 6.25
18% PEG 2000
MME 0.1M MgCl2
0.1%
LDAO 12.5
The additives listed in Table 5.2.3.2 do not have same effect on Wzi crystallization, as
shown in table 5.2.3.3, the salt Li2SO4 and NaCl gave more hits than other salts. This
suggestions that the salt Li2SO4 and NaCl might be more favored in comparison with other
salt/additives. We therefore set up a further optimized kit focusing on the salt Li2SO4 and
NaCl. Table 5.2.3.4 summarized the conditions that were used for the further optimization.
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Table 5.2.3.4 Further optimization conditions for Wzi crystallization.
0.1M Sodium Cacodylate pH 6.25/pH6.0
Salts
PEG2000
MME Li2SO4 Li2SO4 Li2SO4+NaCl NaCl NaCl NaCl+Li2SO4
8% 0.1M 0.05M 0.05M+0.05M 0.05M 0.1M 0.1M+0.1M
10% 0.1M 0.05M 0.05M+0.05M 0.05M 0.1M 0.1M+0.1M
12% 0.1M 0.05M 0.05M+0.05M 0.05M 0.1M 0.1M+0.1M
14% 0.1M 0.05M 0.05M+0.05M 0.05M 0.1M 0.1M+0.1M
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5.2.4 X-ray data collection
Crystals started to grow within two weeks in the second round optimized conditions. One
of the crystals from the following condition diffracted to 2.4Å at Diamond beamline IO4:
protein purified in 0.1% LDAO with a concentration of 12.5 mg/ml, 0.1M sodium
cacodylate pH 6.25, PEG2000 MME 14%, 0.1M NaCl, in cold room temperature.
Data were processed with MOSFLM (Leslie, 2006). Indexing of two diffraction images (0°,
90°) indicated the crystal had a space group of P222, with unit-cell parameters a=64.2Å,
b=64.5Å, c=159.9Å, α=β=γ=90°. A 90° of data was collected with exposure time 5s for 
each 0.5° image. The X-rays had a wavelength of 0.971Å. Data were integrated in
MOSFLM but further scaling using the program SCALA was not successful. Attempts
using HKL2000 and XDS also failed to scale the data. Careful investigation into the
diffraction images revealed that the crystal had deteriorated after 35° rotation (Figure
5.2.4.1).
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(A) (B)
Figure 5.2.4.1 X-ray diffraction pattern of Wzi C-terminal histidine tagged protein crystal,
collected at Diamond IO4. (A) Diffraction pattern at 0°, the highest resolution is about 2.4
Å at the edge. (B) Diffraction pattern after 35° rotation the spots became smeary and the
highest resolution dropped down to less than 3.0 Å.
5.2.5 Is Wzi a monomer?
Previous studies suggested that Wzi is a monomer in solution (Rahn et al., 2003). This
conclusion was based on dynamic light scattering and SDS-PAGE. Dynamic light
scattering predicted a molecular mass of 52KDa which is in agreement with the
monomeric behaviour. The result from SDS-PAGE is less clear. We wished to check the
possibility of Wzi being a monomer by applying the gel filtration technique. A sample of
mixtures of proteins with known molecular mass was used as the background standard.
The peaks in the chromatogram with corresponding molecular weights appeared in an
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order as shown in figure 5.2.5.1. The peak for Wzi-His6 appeared at approximately the
position of ovalbumim, which has a molecular mass of 44kDa. This result is in agreement
with other data that suggests Wzi is more likely a monomer.
Figure 5.2.5.1 Gel filtration of Wzi-His6 (blue curve) and the standard proteins (red curve).
The peaks in the red curve correspond to the following proteins with order: The first peak
is thyroglobulin (MW 670,000 Da); the second peak corresponds to γ-globulin (MW: 
158,000 Da); the third belongs to ovalbumin (MW: 44,000 Da), four belongs to myoglobin
(MW: 17,000 Da) and peak five corresponds to the small protein vitamin B12 (MW: 1,350
Da).
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5.2.6 Structure prediction by online server
The sequence of Wzi starting from AQA was submitted to the Phyre serve (Protein
Homology/analogY Recognition Engine) for structure prediction (Kelley and Sternberg,
2009). Developed by Imperial College London, Phyre uses homologies or analogies of
known protein structure to predict new protein structure (Kelley and Sternberg, 2009). By
submitting the amino acids sequence to the server, a predicted PDB file is sent back and
the predicted structure can be investigated.
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5.3 Discussions and prospectives
Wzi has been successfully purified and crystallized. There has been no publication yet on
Wzi crystals. However, Wzi was previously crystallized and the best diffraction resolution
was 20Å (K. Beis, PhD thesis, University of St Andrews). Here the crystal quality has been
significantly improved and higher resolution has been achieved to 2.4Å. The parameters:
temperature, salts (additives), buffer pH and the choice of detergents, that influence the
crystallization process were investigated. For Wzi C-his6 protein, cold room temperature
turns out to be more successful than normal room temperature. Small salts like NaCl and
Li2SO4 facilitates the crystallization. The detergent LDAO is the most successful one in
comparison with other choices.
It was previously suggested that Wzi is a β-barrel protein (Rahn et al., 2003). Results from 
Phyre server indicated that Wzi is highly likely a β-barrel. Residue 114 to 459 was 
predicted to be an open β-barrel with 12 β-strands, as shown in figure 5.3.1. The shape of 
the predicted β-barrel is like the monomer of OmpC porin. However with the first 114 
residues missing, the β-barrel from X-ray crystal structure might have different shape or 
even more strands as there’s still room left. In an attempt to predict the structure of the first
114 residues of Wzi, Phyer gave a model for the first 77 residues as shown in Figure 5.3.2.
This N-terminal three helix motif has been seen in 14 β-strands outer membrane protein 
TodX and FadL as described in Figure 1.3.4.6, Chapter 1. Both TodX and FadL are
transporters. It is possible that Wzi shares a similar structure with these 14 β-strands 
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proteins, however, the inwarded loop inside the barrel in figure 5.3.1 has to be placed
elsewhere in that case. Wzi is probably a completely new structure that is not seen before.
Figure 5.3.1 Cartoon model of Wzi predicted by Phyre server from residues 114 to 459.
The C terminal loop is colored mengenta.
Figure 5.3.2 Cartoon model of Wzi from residue 2 to 77.
The crystallised form of Wzi in this project is C-terminal His6 tagged. For future work,
further crystallization optimization might be desirable. From the predicted structure model,
there are extracellular long loops especially at the C-terminal (colored mengenta). The long
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loops are usually structurally flexible thus bring disorders to affect the crystal quality. The
C-terminal residues may be truncated to make it shorter loop. Homologues of Wzi found in
K. pneumoniae (Rahn et al. 2003) could be cloned and the structure of the homologue may
provide more amenable crystals. As no homologous’ structures have been known yet, it
might be desirable to use heavy metal soaking strategy for solving the structure. 12 or 14
β-strands known structures can be used as models for molecular replacement to reveal the 
Wzi β-barrel. For its functional properties, single channel conductance measurement might 
provide some insights. Wzi crystals soaking with polysaccharides might also provide
detailed information on the structure and function relationship.
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